- Home
- Software Solutions
- Resources
- Corporate
Bristol-Myers Squibb
Bristol-Myers Squibb Clinical Studies by Phase of Development
Active Clinical Trials 
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Active | Hormone-Refractory Prostate Cancer | >Dasatinib | Phase_II | Trial of Dasatinib (Spryc... | NCT00570700 |
| Active | Breast Cancer | >Ixabepilone | Phase_II | Randomized Study of Ixabe... | NCT00877500 |
| Active | Islets of Langerhans Transplantation Diabetes Mellitus, Type 1 Kidney Transplantation | >Belatacept | Calcineurin Inhibitor-fre... | NCT01033500 | |
| Active | Venous Thrombosis | >Enoxaparin >warfarin >Placebo for apixaban >Placebo for enoxaparin >Placebo for warfarin >apixaban | Phase_III | Efficacy and Safety Study... | NCT00643201 |
| Active | Stomach Neoplasms | >Ixabepilone | Phase_II | Study of Ixabepilone in A... | NCT00983801 |
| Active | Leukemia | >Dasatinib | Phase_I | Study of BMS-354825 in Ch... | NCT00306202 |
| Active | Hepatitis B, Chronic | >Entecavir >Tenofovir >Adefovir >Lamivudine | Phase_III | Entecavir Plus Adefovir C... | NCT00410202 |
| Active | Venous Thrombosis Pulmonary Embolism | >Apixaban >Enoxaparin | Phase_III | Study of Apixaban for the... | NCT00457002 |
| Active | Arthritis, Rheumatoid | >Abatacept | Phase_III | Phase IIIB Switching From... | NCT00663702 |
| Active | Stomach Neoplasms Esophageal Neoplasms | >BMS-833923 >Cisplatin >Capecitabine | Phase_I | A Study of BMS-833923 Wit... | NCT00909402 |
| Active | Heart Defects, Congenital | >clopidogrel (SR25990C) >placebo | Phase_III | Long Term Safety of Clopi... | NCT00833703 |
| Active | Lung Cancer | >Dasatinib | Phase_II | Dasatinib in Advanced Non... | NCT00858403 |
| Active | Type 2 Diabetes Mellitus | >Saxagliptin >Glimepiride | Phase_IV | Saxagliptin Compared to G... | NCT01006603 |
| Active | Advanced Breast Cancer | >Dasatinib | Phase_II | Phase II Dasatinib Study ... | NCT00546104 |
| Active | Solid Tumor | >ixabepilone and dasatinib | Phase_I | Solid Tumors Using Ixabep... | NCT00717704 |
| Active | Breast Cancer | >BMS-690514 >Lapatinib >Letrozole | Phase_II | Efficacy and Safety of BM... | NCT01068704 |
| Active | Breast Cancer | >Ixabepilone >Cyclophosphamide | Phase_II | Ixabepilone and Cyclophop... | NCT00866905 |
| Active | Renal Cell Carcinoma Non-Hodgkin's Lymphoma | >MDX-1203 | Phase_I | Study of MDX-1203 in Subj... | NCT00944905 |
| Active | Non Small Cell Lung Cancer (NSCLC) | >Cetuximab (Erbitux, C225) | Phase_II | Study of Cetuximab With R... | NCT00492206 |
| Active | Ankylosing Spondylitis | >abatacept | Phase_II | Pilot Open Label Clinical... | NCT00558506 |
| Active | Hepatitis B | >Entecavir | Hepatitis B Virus (HBV) V... | NCT00704106 | |
| Active | Breast Cancer | >Fulvestrant >MK-0646 >Dasatinib | Phase_I Phase_II | Trial of Fulvestrant, MK-... | NCT00903006 |
| Active | Chronic Hepatitis B Virus, Pediatric | >Entecavir >Placebo | Phase_III | A Phase III Study of the ... | NCT01079806 |
| Active | Diabetes Mellitus, Type 2 | >Observational Study | Risk of Hospitalized Infe... | NCT01086306 | |
| Active | Hepatitis B | >Entecavir >Adefovir | Phase_III | Comparison of Entecavir t... | NCT00065507 |
| Active | Type 2 Diabetes | >Saxagliptin >Placebo >Saxagliptin >Metformin | Phase_III | A Study Assessing Saxagli... | NCT00374907 |
| Active | Type 2 Diabetes | >dapagliflozin >glipizide >metformin hydrochloride | Phase_III | Efficacy and Safety of Da... | NCT00660907 |
| Active | Advanced Melanoma | >Ipilimumab | Phase_I | Comparison of Ipilimumab ... | NCT00920907 |
| Active | Type 2 Diabetes Mellitus (T2DM) | >Dapagliflozin >Metformin XR >Glucophage | Phase_I | Bioavailability Study of ... | NCT01002807 |
| Active | Esophageal Gastroesophageal Gastric Cancer | >Cetuximab >Paclitaxel >Carboplatin | Phase_II | BrUOG-EG-203 Cetuximab, P... | NCT00439608 |
| Active | Chronic Hepatitis C | >BMS-790052 >Placebo | Phase_II | A Multiple Ascending Dose... | NCT00663208 |
| Active | Chronic Hepatitis C | >BMS-824393 >BMS-824393 >BMS-824393 >BMS-824393 >BMS-824393 | Phase_I | Multiple Dose Study In Tr... | NCT00971308 |
| Active | Sarcoma | >Cetuximab | Phase_II | Trial of Cetuximab in Pat... | NCT00148109 |
| Active | Attention Deficit Hyperactivity Disorder | >aripiprazole | Phase_II | Treatment of Children Wit... | NCT00279409 |
| Active | Prostatic Diseases Genital Neoplasms, Male Urogenital Neoplasms Genital Diseases, Male Adenocarcinoma Prostatic Neoplasms Neoplasms, Glandular and Epithelial Carcinoma | >Ixabepilone | Phase_II | A Study of Ixabepilone Be... | NCT00672009 |
| Active | Scleroderma | >dasatinib | Phase_I Phase_II | Safety Evaluation of Dasa... | NCT00764309 |
| Active | Schizophrenia | >Aripiprazole >Risperidone | Phase_IV | Metabolic Signatures and ... | NCT00466310 |
| Active | Colorectal Cancer | >5-FU >Cetuximab >Dasatinib >Leucovorin >Oxaliplatin | Phase_I | FOLFOX Chemotherapy Regim... | NCT00501410 |
| Active | Melanoma | >Ipilimumab >Bevacizumab | Phase_I | Bevacizumab Plus Ipilimum... | NCT00790010 |
| Active | Prostate Cancer | >Ipilimumab >Placebo | Phase_III | Phase 3 Study of Immunoth... | NCT01057810 |
| Active | Scleroderma, Diffuse Scleroderma, Systemic | >Abatacept | Phase_I Phase_II | A Study to Evaluate the S... | NCT00442611 |
| Active | Colon Cancer | >Peri operative Cetuximab. | Phase_I | A Study of the Perioperat... | NCT00494611 |
| Active | Rectal Cancer | >Cetuximab | Phase_II | Pre-op Rectal ChemoRad +/... | NCT00527111 |
| Active | Glioblastoma Multiforme | >CT-322 >Temozolomide >Radiation Therapy | Phase_I | CT-322 in Combination Wit... | NCT00768911 |
| Active | Coronary Artery Disease Acute Coronary Syndrome | >Aspirin and clopidogrel >VerifyNow >Aspirin and clopidogrel >Aspirin and clopidogrel >Aspirin | Phase_IV | Double Randomization of a... | NCT00827411 |
| Active | Bipolar Disorder | >abilify (aripiprazole) | Phase_III | Study of Aripiprazole (Ab... | NCT00194012 |
| Active | Hepatitis C Infection | >BMS-790052 >BMS-790052 >Placebo >Peginterferon alfa-2b >Ribavirin | Phase_II | Safety and Efficacy of BM... | NCT01016912 |
| Active | Non-squamous Non-small Cell Lung Cancer | >ixabepilone >bevacizumab | Phase_II | Trial of Bevacizumab and ... | NCT01057212 |
| Active | AIDS HIV Infection | >(A) zidovudine, lamivudine and nevirapine >(B) zidovudine, lamivudine and efavirenz >(C) zidovudine, didanosine, and nevirapine >(D) zidovudine, didanosine, and efavirenz >(E) stavudine, lamivudine, and nevirapine >(F) stavu | Phase_III | The Adult Antiretroviral ... | NCT00197613 |
| Active | Renal Transplantation | >Thymoglobulin >Belatacept >Sirolimus >Tacrolimus >Mycophenolate Mofetil (MMF) | Phase_II | A Phase II Study of Belat... | NCT00455013 |
| Active | Psoriatic Arthritis | >Abatacept >placebo | Phase_II | Safety and Efficacy of Ab... | NCT00534313 |
| Active | Prostate Cancer | >Ipilimumab >Placebo | Phase_III | Study of Immunotherapy to... | NCT00861614 |
| Active | HIV-1 Infections | >BMS-663068 with or without ritonavir | Phase_II | Pharmacodynamics, Safety ... | NCT01009814 |
| Active | Alzheimer Disease | >Donepezil >BMS-708163 | Phase_I | Drug-Drug Interaction Stu... | NCT01042314 |
| Active | Hepatitis C Infection | >BMS-790052 >BMS-650032 | Phase_II | An Anti-viral Combination... | NCT01051414 |
| Active | Non-Small-Cell Lung Carcinoma | >Erlotinib in combination with Dasatinib | Phase_I | Phase I Dasatinib/Erlotin... | NCT00444015 |
| Active | Non-Hodgkin's Lymphoma | >Dasatinib >Dasatinib >Dasatinib | Phase_I Phase_II | Dasatinib in Relapsed or ... | NCT00550615 |
| Active | Psychiatry | Comparison of Bone Minera... | NCT00573716 | ||
| Active | Endometrial Cancer | >Ixabepilone >Doxorubicin >Paclitaxel | Phase_III | A Study of Ixabepilone as... | NCT00883116 |
| Active | Neoplasms | >BMS-754807 | Phase_I | Multiple Ascending Dose S... | NCT00898716 |
| Active | Alzheimer Disease | >BMS-708163 >BMS-708163 >Placebo >Moxifloxacin | Phase_I | Effect on the Electrocard... | NCT00979316 |
| Active | Bipolar Disorder | >Aripiprazole | Aripiprazole in the Treat... | NCT00226317 | |
| Active | Advanced Solid Tumors | >Epofolate | Phase_I Phase_II | A Phase 1/2 Study of Epof... | NCT00550017 |
| Active | Non Small Cell Lung Cancer | >Ixabepilone >Cisplatin >Ixabepilone >Cisplatin | Phase_I | Phase I Combination Ixabe... | NCT00832117 |
| Active | Type 2 Diabetes Mellitus | >Saxagliptin >Saxagliptin >Metformin >Metformin | Phase_I | Bioequivalence Study of 2... | NCT01068717 |
| Active | Schizophenia Disorder Schizoaffective Disorder | >aripiprazole | Study Comparing Patients ... | NCT00223418 | |
| Active | Hepatitis B, Chronic | >Entecavir | Phase_III | Antiviral Activity of Ent... | NCT00395018 |
| Active | Breast Cancer Bone Metastases | >Dasatinib >Zoledronic Acid | Phase_I Phase_II | Dasatinib in Combination ... | NCT00566618 |
| Active | Schizophrenia Schizoaffective Disorder Bipolar I Disorder Metabolic Syndrome | >Aripiprazole >Olanzapine >Risperidone >Quetiapine | Phase_III | Metabolic Abnormalities -... | NCT00857818 |
| Active | Colon Cancer | >bevacizumab >cetuximab >5-fluorouracil >leucovorin >oxaliplatin | Phase_II | Bevacizumab and Cetuximab... | NCT00193219 |
| Active | Brain and Central Nervous System Tumors Recurrent Glioblastoma Multiforme | >CT-322 >irinotecan hydrochloride | Phase_II | CT-322 in Treating Patien... | NCT00562419 |
| Active | Alzheimer's Disease | >BMS-708163 >BMS-708163 >Placebo >Placebo | Phase_I | Study to Evaluate the Pha... | NCT01079819 |
| Active | Diabetes Mellitus, Type 2 | Risk of Hospitalization f... | NCT01086319 | ||
| Active | Rhabdomyosarcoma Malignant Peripheral Nerve Sheath Tumors Chondrosarcoma Sarcoma, Ewing's Sarcoma, Alveolar Soft Part Chordoma Epithelioid Sarcoma Giant Cell Tumor of Bone Hemangiopericytoma Gastrointestinal Stromal Tumor (GIST) | >Dasatinib | Phase_II | Trial of Dasatinib in Adv... | NCT00464620 |
| Active | Breast Cancer | >Exemestane + Dasatinib >Exemestane + Placebo | Phase_II | Safety and Efficacy of Ex... | NCT00767520 |
| Active | Coronary Artery Disease | Genotype Information and ... | NCT00992420 | ||
| Active | Rheumatoid Arthritis (RA) | >abatacept | Phase_III | Phase IIIB Subcutaneous A... | NCT00547521 |
| Active | Immunosuppression in Solid Organ Transplant | >Basiliximab+Belatacept (MI) + MMF >Belatacept (MI) + MMF >Belatacept (LI) + MMF >Tacrolimus + MMF >Tacrolimus | Phase_II | Belatacept in Liver Trans... | NCT00555321 |
| Active | Rheumatoid Arthritis | >Observational Study | Safety Study of Abatacept... | NCT01088321 | |
| Active | HIV | >stavudine | Phase_IV | Evaluation of Viral Effic... | NCT00235222 |
| Active | Type 2 Diabetes Mellitus | >Metformin XR | Phase_IV | Body Weight Effects on Gl... | NCT00778622 |
| Active | Diabetes Type 2 | >BMS-770767 >BMS-770767 >BMS-770767 >BMS-770767 >Placebo >Metformin | Phase_II | Safety Study of BMS-77076... | NCT01046422 |
| Active | Melanoma | >Ipilimumab >Ipilimumab | Phase_II Phase_III | A Companion Study for Pat... | NCT00162123 |
| Active | Atherosclerosis | >Clopidogrel 75 mg daily | Phase_II | Trial of Clopidogrel Afte... | NCT00228423 |
| Active | Chronic Myelogenous Leukemia | >Dasatinib (BMS-354825) | Phase_II | Study of Dasatinib in Pat... | NCT00254423 |
| Active | Healthy | >tenofovir, emtricitabine and efavirenz fixed dose tablet >tenofovir, emtricitabine and efavirenz tablet added to solution | Phase_IV | The Bioequivalence of Atr... | NCT00862823 |
| Active | Hepatitis C Virus | >Ortho Tri-Cyclen® >BMS-650032 | Phase_I | Drug Interaction Oral Con... | NCT01063023 |
| Active | Carcinoma, Hepatocellular | >Brivanib | Phase_I | A Study of Brivanib (BMS-... | NCT00437424 |
| Active | Colorectal Cancer Head and Neck Cancer Neoplasm Metastasis | >BMS-754807 >cetuximab (Erbitux®) | Phase_I Phase_II | Combination Study of BMS-... | NCT00908024 |
| Active | Leukemia Acute Lymphoblastic Leukemia | >Dasatinib, Mitoxantrone, Cytarabine | Phase_I | Induction Therapy With Cy... | NCT00940524 |
| Active | Urologic Neoplasm | >Cetuximab >Paclitaxel | Phase_II | Study of Cetuximab With a... | NCT00350025 |
| Active | Advanced Breast Cancer | >Dasatinib + Fulvestrant >Fulvestrant | Phase_II | Randomized Trial of Fulve... | NCT00754325 |
| Active | Rheumatoid Arthritis | >Abatacept | Phase_III | A Rheumatoid Arthritis St... | NCT00767325 |
| Active | Rheumatoid Arthritis | >Observational Study | Abatacept Pregnancy Expos... | NCT01087125 | |
| Active | Obesity Overweight Healthy | >PF-04620110 >Placebo | Phase_I | A Multiple Dose Study Of ... | NCT00959426 |
| Active | Schizophrenia | >Aripiprazole (drug) | The Effects of Aripiprazo... | NCT00209027 | |
| Active | Advanced Solid Malignancies | >Dasatinib (BMS-354825) >Cetuximab (Erbitux, C225) | Phase_I | Safety Study Of Cetuximab... | NCT00388427 |
| Active | Esophageal Adenocarcinoma | >Capecitabine >Oxaliplatin >Cetuximab | Trial of Preoperative Cap... | NCT00430027 | |
| Active | Metastatic Breast Cancer | >Ixabepilone | Phase_II | Phase II Trial of Weekly ... | NCT00593827 |
| Active | Pervasive Developmental Disorder | >aripiprazole | Phase_III | Study of Aripiprazole in ... | NCT00870727 |
| Active | Medication Non-adherence Stent Thrombosis | Patterns of Non-Adherence... | NCT00998127 | ||
| Active | Hepatocellular Carcinoma | >Cetuximab | Phase_II | Cetuximab in Patients Wit... | NCT00142428 |
| Active | Melanoma | >Dasatinib | Phase_II | Treatment With Dasatinib ... | NCT01092728 |
| Active | Burns | Phase_IV | Fluid Shifts During Resus... | NCT00326729 | |
| Active | Breast Cancer | >Carboplatin >Cetuximab | Phase_II | Cetuximab and Carbo for E... | NCT00420329 |
| Active | Alzheimer Disease | >BMS-708163 >Placebo | Phase_I | Multiple Dose Japanese Br... | NCT01057030 |
| Active | Type 2 Diabetes Mellitus | >Metformin (Diabex) >Metformin (Glucophage™) >Metformin (Diabex) >Metformin (Glucophage™) | Phase_I | Bioequivalence Study of 5... | NCT01068730 |
| Active | Breast Cancer | >UFT/LV >Observation | Phase_III | UFT/LV Maintenance Vs Obs... | NCT00189631 |
| Active | Non-Small Cell Lung Cancer | >Cetuximab >Cetuximab and Pemetrexed | Phase_II | Trial Comparing Cetuximab... | NCT00203931 |
| Active | Type 2 Diabetes | >Dapagliflozin >Dapagliflozin >Dapagliflozin >Placebo >Dapagliflozin >Dapagliflozin | Phase_III | Efficacy and Safety of Da... | NCT00673231 |
| Active | Malignant Melanoma | >BMS-936558 (MDX1106-04) >Ipilimumab | Phase_I | Dose-escalation Study of ... | NCT01024231 |
| Active | Breast Cancer | >Epirubicin >Paclitaxel >Cyclophosphamide >Darbepoetin | Phase_III | Preoperative Epirubicin P... | NCT00544232 |
| Active | Rheumatoid Arthritis | >Abatacept >Abatacept >Abatacept >Placebo | Phase_II Phase_III | Efficacy, Pharmacokinetic... | NCT01001832 |
| Active | Hepatitis C Virus | >BMS-650032 >BMS-650032 >BMS-650032 >BMS-650032 >Peginterferon Alfa-2a >Peginterferon Alfa-2a >Ribavirin >Ribavirin | Phase_II | Study of BMS-650032 With ... | NCT01030432 |
| Active | Esophageal Cancer | >carboplatin, 5FU, Taxol and radiation | Phase_II | Selective Dose Escalation... | NCT00139633 |
| Active | Breast Cancer | >Ixabepilone >Paclitaxel >Cyclophosphamide >Doxorubicin | Phase_II | Study to Assess Effective... | NCT00455533 |
| Active | Breast Cancer | >BMS-754807 >trastuzumab (Herceptin®) | Phase_I Phase_II | Combination Study of BMS-... | NCT00788333 |
| Active | Melanoma | >ipilimumab | Immunogenicity and Biomar... | NCT00972933 | |
| Active | Advanced Cancer Solid Tumors | >Dasatinib >Gemcitabine | Phase_I | Gemcitabine and Dasatinib... | NCT00429234 |
| Active | Kidney Cancer | >MDX 1411 | Phase_I | Study of MDX-1411 Given E... | NCT00656734 |
| Active | Metastatic Breast Cancer | >Sorafenib and Ixabepilone >Sorafenib and Ixabepilone | Phase_I Phase_II | Phase I/II Trial of Soraf... | NCT00825734 |
| Active | HIV Infection AIDS | >once daily minimum 3-drug regimen of anti-retroviral medications | Phase_IV | Once Daily 3TC, Efavirenz... | NCT00214435 |
| Active | Lung Cancer Small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung | >Ipilimumab and Taxol and Paraplatin (concurrent) >Ipilimumab and Taxol and Paraplatin (sequential) >Ipilimumab placebo and Taxol and Paraplatin | Phase_II | Phase II Study for Previo... | NCT00527735 |
| Active | Rheumatoid Arthritis | >Abatacept >Abatacept | Phase_III | Substudy - Low Dose of Ab... | NCT00989235 |
| Active | Solid Tumor | >Brivanib | Phase_I | A Study of BMS-582664 in ... | NCT00390936 |
| Active | Neoplasms Solid Tumors Metastases | >BMS-754807 | Phase_I | Multiple Dose Study In Ca... | NCT00569036 |
| Active | Leukemia | >Dasatinib >Dasatinib | Phase_II | A Phase II Study of Dasat... | NCT00777036 |
| Active | Chronic Hepatitis B | >Entecavir >Tenofovir | Phase_III | Efficacy and Safety Study... | NCT01063036 |
| Active | Peripheral Arterial Disease Hypercholesterolemia Hypertension Diabetes Mellitus Smoking | >Stepwise therapy for dyslipidemia, hypertension and diabetes >Dietary recommendations >Increase in physical activity >Smoking cessation | Phase_IV | Multifactorial Interventi... | NCT00144937 |
| Active | Tumors | >Brivanib | Phase_I | A Phase I Study to Determ... | NCT00437437 |
| Active | Hepatocellular Carcinoma (HCC) | >brivanib (active) | Phase_II | A Phase II Open Label Stu... | NCT00355238 |
| Active | Metastatic Melanoma | >Dasatinib and Dacarbazine | Phase_I Phase_II | A Phase I/II Study of Das... | NCT00597038 |
| Active | Lung Cancer | >Cetuximab | Phase_II | Cetuximab Plus Conformal ... | NCT00673738 |
| Active | Non Small Cell Lung Cancer | >BMS-690514 >Erlotinib | Phase_II | A Comparison Between BMS-... | NCT00743938 |
| Active | Type 2 Diabetes | >Saxagliptin >Metformin XR >Placebo matching Metformin 500 mg >Metformin XR >Placebo matching Saxagliptin 5 mg | Phase_III | Study to Evaluate 24 Hour... | NCT00918138 |
| Active | Coronary Artery Disease | >Placebo & Aspirin >Clopidogrel & Aspirin, Prasugrel & Aspirin | Phase_IV | The Dual Antiplatelet The... | NCT00977938 |
| Active | Peripheral Vascular Diseases | Screening DIVA - Diffuse ... | NCT01076738 | ||
| Active | HIV Infections Pregnancy | >Didanosine | Phase_I | A Phase I Trial to Evalua... | NCT00000839 |
| Active | Breast Cancer | >Herceptin >Taxol >Adriamycin >Cytoxan | Phase_II | Neoadjuvant Therapy With ... | NCT00136539 |
| Active | Cancer | >Docetaxel >Cisplatin >Cetuximab >Radiation Therapy | Phase_II | Docetaxel, Cetuximab and ... | NCT00226239 |
| Active | Tourette's Syndrome | >Aripiprazole | Aripiprazole in the Treat... | NCT00282139 | |
| Active | Pancreatic Cancer | >Cetuximab >Gemcitabine >Oxaliplatin >Capecitabine >Radiotherapy | Phase_II | Induction Cetuximab (IM-C... | NCT00338039 |
| Active | HIV Infections Atherosclerosis | Antiretrovirals and Rate ... | NCT00575939 | ||
| Active | Metastatic Castration-resistant Prostrate Cancer (mCRPC) Renal Cell Carcinoma (RCC) Malignant Melanoma (MEL) Non-small Cell Lung Cancer (NSCLC) | >MDX-1106 | Phase_I | A Phase 1b Study of MDX-1... | NCT00730639 |
| Active | Psychotic Depression | >Aripiprazole | Phase_III | The Combination of Aripip... | NCT00556140 |
| Active | Depression | >BMS-820836 >Placebo | Phase_I | Multiple-Ascending Dose S... | NCT00892840 |
| Active | Diabetes Mellitus, Type 2 | >Saxagliptin >Saxagliptin >Saxagliptin >Placebo matching Saxagliptin >Metformin >Placebo matching Metformin >Saxagliptin >Metformin | Phase_III | Saxagliptin Treatment in ... | NCT00121641 |
| Active | Transitional Cell Carcinoma of the Bladder | >Dasatinib >Radical Cystectomy | Neoadjuvant Dasatinib and... | NCT00706641 | |
| Active | Acute Coronary Syndrome | >Apixaban >Placebo | Phase_III | Phase III Acute Coronary ... | NCT00831441 |
| Active | Esophageal Cancer | >Paclitaxel | Phase_II | Rollover Study of Weekly ... | NCT00971841 |
| Active | Esophageal Cancer Gastric Cancer | >ixabepilone | Phase_II | BMS-247550 in Treating Pa... | NCT00017043 |
| Active | Bipolar Disorder | >Lithium or Valproate with PBO >Lithium or Valproate with Aripiprazole | Phase_IV | A Study of Aripiprazole (... | NCT00261443 |
| Active | Major Depressive Disorder | >Aripiprazole | Phase_IV | Abilify Augmentation of S... | NCT00608543 |
| Active | Type 2 Diabetes Mellitus | >Saxagliptin >Metformin | Phase_I | Bioequivalence Study of 2... | NCT01068743 |
| Active | Breast Cancer | >6 FEC 100 >4 FEC 100 followed by 4 Taxol | Phase_III | 6 FEC 100 Vs 4 FEC 100 Fo... | NCT00189644 |
| Active | Type 2 Diabetes Mellitus | >Dapagliflozin >Placebo | Phase_II | Trial to Evaluate the Eff... | NCT00972244 |
| Active | Myocardial Infarction | >Irbesartan | Phase_IV | Left Ventricular Function... | NCT00125645 |
| Active | HIV Infections Hepatitis B | >Entecavir with continued standard of care antiretroviral therapy >continued standard of care with tenofovir in addition to emtricitabine or lamivudine | Phase_IV | Entecavir Intensification... | NCT00662545 |
| Active | Type 2 Diabetes | >dapagliflozin >Glimepiride >metformin hydrochloride >pioglitazone hydrochloride >Rosiglitazone | Phase_III | Efficacy and Safety of Da... | NCT00680745 |
| Active | Migraine | >Clopidogrel | Phase_IV | Clopidogrel For the Preve... | NCT00799045 |
| Active | Colorectal Cancer (CRC) | >Irinotecan >5-Fluorouracil (bolus) >5-Fluorouracil (infusional) >Leucovorin calcium >CT-322 >Bevacizumab >Bevacizumab Placebo (saline solution) | Phase_II | Ph II Trial of a Novel An... | NCT00851045 |
| Active | Hepatitis C Virus | >BMS-791325 >BMS-791325 >BMS-791325 >BMS-791325 >BMS-791325 >BMS-791325 >Placebo >Placebo >Placebo >Placebo | Phase_I | Japanese Bridging Study C... | NCT00947245 |
| Active | Neoplasms | >BMS-907351 (XL184) | Phase_I | Multiple Ascending Dose S... | NCT01018745 |
| Active | Acute Myeloid Leukemia Myelodysplastic Syndromes Agnogenic Myeloid Metaplasia Myelofibrosis Hypereosinophilic Syndrome Polycythemia Vera Mastocytosis Leukemia, Myelomonocytic, Chronic | >Dasatinib (BMS-354825) | Phase_II | Dasatinib as Therapy for ... | NCT00255346 |
| Active | Non-Small Cell Lung Cancer | >Vinflunine | Phase_II | A Phase II Single Arm Tri... | NCT00251446 |
| Active | Metastatic Breast Cancer | >Ixabepilone & Trastuzumab >Docetaxel & Trastuzumab | Phase_II | A Phase II Combination of... | NCT00490646 |
| Active | Gastric Cancer Stomach Cancer | >Induction including Cetuximab/ surgery/ chemoradiation | Phase_II | Pre-operation Chemo and A... | NCT00857246 |
| Active | Advanced Cancer, Various, NOS | >BMS-833923 >Lenalidomide >Dexamethasone >Bortezomib | Phase_I | Multiple Ascending Dose (... | NCT00884546 |
| Active | Myeloid Leukemia, Chronic | >Dasatinib >Imatinib | Phase_III | A Phase III Study of Dasa... | NCT00481247 |
| Active | Advanced Solid Tumors | >Epofolate | Phase_I Phase_II | A Phase 1/2 Study of Epof... | NCT00546247 |
| Active | Metastatic Colorectal Cancer | >cetuximab >5-FU >oxaliplatin >leucovorin | Phase_II | A Study With Neoadjuvant ... | NCT00803647 |
| Active | Alzheimer's Disease | >BMS-708163 >BMS-708163 >BMS-708163 >BMS-708163 >Placebo | Phase_II | A Phase II, Multicenter, ... | NCT00810147 |
| Active | Chronic Lymphocytic Leukemia Leukemia | >dasatinib and lenalidomide | Phase_I Phase_II | A Study Using Two Oral Ch... | NCT00829647 |
| Active | Brain Infarction Transient Ischemic Attack Embolism | >Clopidogrel + aspirin | Phase_III | Aortic Arch Related Cereb... | NCT00235248 |
| Active | Renal Transplantation | >Belatacept | Phase_II | Belatacept Pharmacokineti... | NCT00578448 |
| Active | Lung Cancer Non-small Cell Lung Cancer | >Dasatinib >Erlotinib | Phase_I Phase_II | Dasatinib and Erlotinib i... | NCT00826449 |
| Active | Rheumatoid Arthritis | >Self-Help Group >Education (Control) Group | Living Well With Rheumato... | NCT00869349 | |
| Active | Kidney Transplantation Chronic Kidney Failure | >CsA >Belatacept LI >Belatacept MI | Phase_III | Belatacept Evaluation of ... | NCT00256750 |
| Active | Hepatitis B Infection | >Entecavir | Phase_IV | Effect of Entecavir in Bl... | NCT00371150 |
| Active | Multiple Myeloma | >Dasatinib >Bortezomib >Dexamethasone | Phase_I | Safety Study of Dasatinib... | NCT00560352 |
| Active | Vascular Diseases | >Placebo + background low to moderate dose statin >BMS-582949 + Background low to moderate dose statin >Atorvastatin | Phase_II | Efficacy Study of p38 Kin... | NCT00570752 |
| Active | Hodgkin's Lymphomas | >MDX-1401 | Phase_I | Phase 1 Study of MDX-1401... | NCT00634452 |
| Active | Major Depressive Disorder | >Aripiprazole >Aripiprazole >Placebo | Phase_III | A Double-Blind, Placebo-C... | NCT00683852 |
| Active | Advanced Cancer | >Capecitabine >Doxorubicin >Ixabepilone >Docetaxel >Paclitaxel >Brivanib alaninate | Phase_I | Ascending Multiple-Dose S... | NCT00798252 |
| Active | Hepatocellular Carcinoma | >Brivanib >Brivanib Placebo | Phase_III | Phase III Trans-Arterial ... | NCT00908752 |
| Active | Metastatic Breast Cancer | >Dasatinib >Ixabepilone | Phase_I Phase_II | Trial of Dasatinib Plus I... | NCT00924352 |
| Active | Type 2 Diabetes Mellitus | >Dapagliflozin | Phase_I | Drug-drug Interaction Stu... | NCT01055652 |
| Active | Lung Cancer | >Gemcitabine >Docetaxel >Cetuximab | Phase_II | Gemcitabine, Docetaxel, a... | NCT00193453 |
| Active | Breast Neoplasm | >Paclitaxel >Doxorubicin >Cyclophosphamide >G-CSF | Phase_II | Adjuvant Therapy for High... | NCT00194753 |
| Active | Squamous Cell Carcinoma | >Radiotherapy >Paclitaxel >Carboplatin | Phase_II | Paclitaxel, Carboplatin a... | NCT00176254 |
| Active | Carcinoma, Small Cell Lung Cancer | >Vinflunine | Phase_II | Vinflunine in the Treatme... | NCT00284154 |
| Active | Chronic Lymphocytic Leukemia | >Dasatinib | Phase_II | Dasatinib in Relapsed Chr... | NCT00438854 |
| Active | Myocardial Infarction Cardiovascular Diseases Pathologic Processes | >KAI-9803 | Phase_II | Safety and Efficacy Study... | NCT00785954 |
| Active | HIV Infections | >Emtricitabine/tenofovir disoproxil fumarate >Raltegravir >Darunavir >Ritonavir | Phase_III | Comparative Study of Thre... | NCT00811954 |
| Active | Chronic Hepatitis C Virus Infection | >PEG-rIL-29 >Peginterferon alfa-2a >Ribavirin | Phase_II | Efficacy and Safety Study... | NCT01001754 |
| Active | Cancer of the Cervix | >Cetuximab | Phase_II | Cetuximab, Cisplatin, and... | NCT00292955 |
| Active | Melanoma | >Ipilimumab and Dacarbazine >Placebo and Dacarbazine | Phase_III | Dacarbazine and Ipilimuma... | NCT00324155 |
| Active | Liver Cancer | >Brivanib >Placebo | Phase_III | Comparison of Brivanib an... | NCT00825955 |
| Active | Schizophrenia | >Aripiprazole | Phase_III | Aripiprazole for Schizoph... | NCT00239356 |
| Active | Colon Cancer Rectum Cancer | >Cetuximab >Irinotecan | Phase_II | Irinotecan and Cetuximab ... | NCT00336856 |
| Active | Lung Adenocarcinoma | >erlotinib along with cetuximab | Phase_I Phase_II | Cetuximab in Patients Wit... | NCT00716456 |
| Active | Type 2 Diabetes Mellitus | >Dapagliflozin >Rifampin | Phase_I | Effect of Rifampin on the... | NCT01068756 |
| Active | Rectal Cancer | >Capecitabine, Oxaliplatin and Cetuximab >Radiation | Phase_II | Capecitabine,Oxaliplatin ... | NCT00353457 |
| Active | Advanced/Metastatic Non-Small Cell Lung Cancer | >Ixabepilone + Carboplatin >Paclitaxel + Carboplatin | Phase_II | A Randomized Phase 2 Stud... | NCT00723957 |
| Active | Stroke Venous Thrombosis Atrial Fibrillation Atrial Flutter | >Genotype-guided dosing algorithm for warfarin >Clinical-guided dosing algorithm for warfarin | Phase_III | Clarification of Optimal ... | NCT00839657 |
| Active | Non Hodgkin's Lymphoma Hepatitis B | >Entecavir prophylaxis >Therapeutic entecavir | Phase_IV | Prophylactic Use of Entec... | NCT00926757 |
| Active | Chronic Hepatitis C | >BMS-790052 >Ortho Tri-Cyclen® | Phase_I | Study to Assess the Effec... | NCT00983957 |
| Active | Rectal Cancer | >Cetuximab >5-Fluorouracil >External Beam Pelvis Radiation Therapy | Phase_II | Cetuximab, 5-FU and Radia... | NCT00611858 |
| Active | Chronic Hepatitis C | >BMS-650032 >Placebo | Phase_II | A Multiple Ascending Dose... | NCT00722358 |
| Active | Prostate Cancer | >Dasatinib >Leuprolide Acetate (LHRH Analogue) >Radical Prostatectomy | Phase_II | Neoadjuvant Dasatinib Plu... | NCT00860158 |
| Active | Chronic Hepatitis B | >Pegasys plus Entecavir >Entecavir | Phase_IV | Pegasys Plus Entecavir Ve... | NCT00597259 |
| Active | Atopic Asthma | >abatacept >Placebo | Phase_II | Costimulation Inhibition ... | NCT00784459 |
| Active | Hodgkin's Lymphoma | >Rituximab and ABVD >ABVD | Phase_III | Study Evaluating the Effe... | NCT00816959 |
| Active | Schizophrenia Type 2 Diabetes Mellitus | >ziprasidone >risperidone >olanzapine >quetiapine >aripiprazole >aripiprazole >aripiprazole >aripiprazole | Phase_IV | Changes in Adiposity, Met... | NCT00205660 |
| Active | HIV Infections Distal Symmetric Polyneuropathy | >acetyl L-carnitine | Phase_II | ALCAR Prophylaxis Study | NCT00225160 |
| Active | Diabetes Mellitus, Type 2 | >Dapagliflozin >Dapagliflozin >Placebo | Phase_II Phase_III | Glycemic Efficacy and Ren... | NCT00663260 |
| Active | Hematologic Cancer | >elotuzumab (HuLuc63) | Phase_I Phase_II | A Phase 1b/2, Dose-escala... | NCT00742560 |
| Active | Glioblastoma CNS Disease Brain Diseases | >Dasatinib >RT (Radiotherapy) >TMZ (Temozolomide) | Phase_I Phase_II | Dasatinib Plus Radiation ... | NCT00895960 |
| Active | Rheumatoid Arthritis | >Observational Study | Safety Study of Abatacept... | NCT01088360 | |
| Active | Breast Cancer Lung Cancer Colon Cancer Pancreatic Cancer Head and Neck Cancer Kidney Cancer Sarcoma Hepatocellular Cancer | >Pazopanib >Ixabepilone | Phase_I | Study of Pazopanib and Ix... | NCT01012362 |
| Active | Healthy | >3H-Cholesterol | BMS Reverse Cholesterol T... | NCT01031862 | |
| Active | Atherosclerosis Hypercholesterolemia | >BMS-844421 >0.9% sodium chloride injection solution | Phase_I | Safety Study of BMS-84442... | NCT01082562 |
| Active | Breast Cancer | >Paclitaxel | Phase_III | Maintenance Chemotherapy ... | NCT00289263 |
| Active | HIV Infections Contraception Pharmacokinetics | >levonorgestrel, efavirenz | Phase_I | A Study of the Drug Inter... | NCT00482963 |
| Active | Leukemia | >Dasatinib | Phase_II | Dasatinib in Imatinib Res... | NCT00529763 |
| Active | Diffuse Large B-cell Lymphoma | >dasatinib | Phase_II | A Study to Evaluate the S... | NCT00918463 |
| Active | Metastatic Colorectal Cancer | >Bev-FOLFOX >FOLF-CB | Phase_III | Trial of Cetuximab, Bevac... | NCT00252564 |
| Active | Breast Neoplasms | >Ixabepilone >Docetaxel >Capecitabine | Phase_II | This is a Study of Ixabep... | NCT00546364 |
| Active | Triple Negative Locally Advanced Non-resectable Breast Cancer Metastatic Breast Cancer | >ixabepilone >ixabepilone+cetuximab | Phase_II | Randomized Phase II of Ix... | NCT00633464 |
| Active | Renal Cell Carcinoma Non-small Cell Lung Cancer Malignant Melanoma Epithelial Ovarian Cancer Colorectal Adenocarcinoma | >MDX-1105 | Phase_I | Study of MDX-1105 in Subj... | NCT00729664 |
| Active | Rheumatoid Arthritis | >Abatacept >Adalimumab | Phase_III | Abatacept Versus Adalimum... | NCT00929864 |
| Active | Gastro-Intestinal Cancer | >5-FU >Leucovorin >5-FU >Irinotecan >Brivanib >Brivanib >Brivanib | Phase_I | Combination of Brivanib W... | NCT01046864 |
| Active | Accelerated Intimal Hyperplasia | >BMS-813160 >BMS-813160 >BMS-813160 >BMS-813160 >BMS-813160 >BMS-813160 >[14C] BMS-813160 >Placebo | Phase_I | Single Ascending Dose (BM... | NCT01049165 |
| Active | ANCA-Associated Vasculitis | >Abatacept (Orencia) | Phase_II | Abatacept in ANCA Associa... | NCT00482066 |
| Active | Melanoma | >Ipilimumab >Steroids | Phase_II | Study of Ipilimumab to Tr... | NCT00623766 |
| Active | Bipolar Disorder Mania | >Aripiprazole >Placebo | Phase_III | Study to Evaluate the Eff... | NCT00665366 |
| Active | Type 2 Diabetes Mellitus | >Dapagliflozin >Metformin >Sitagliptin >Placebo | Phase_III | Evaluation of the Effect ... | NCT00855166 |
| Active | Obesity | >BMS-830216 >BMS-830216 >BMS-830216 >BMS-830216 >BMS-830216 >BMS-830216 >Placebo | Phase_I Phase_II | Safety, Pharmacokinetics ... | NCT00909766 |
| Active | Diabetes Mellitus, Type 2 | >Saxagliptin + Metformin >Saxagliptin + Metformin >Saxagliptin + Metformin >Placebo + Metformin >Pioglitazone | Phase_III | Study Assessing Saxaglipt... | NCT00121667 |
| Active | Squamous Cell Carcinoma | >Radiotherapy >Paclitaxel >Carboplatin | Phase_II | Paclitaxel, Carboplatin A... | NCT00176267 |
| Active | Atrial Fibrillation Hypertension | >Irbesartan | Phase_III | Irbesartan for the Preven... | NCT00225667 |
| Active | Lupus Nephritis | >Placebo >Abatacept >Abatacept | Phase_I | Phase I Study in China - ... | NCT00705367 |
| Active | Non Small Cell Lung Cancer | >Dasatinib | Phase_II | Phase II Study of Dasatin... | NCT00787267 |
| Active | Depression | >BMS-866949 >BMS-866949 >BMS-866949 >BMS-866949 >BMS-866949 >BMS-866949 >BMS-866949 >Placebo | Phase_I | Safety, Pharmacokinetics ... | NCT00949767 |
| Active | Type 2 Diabetes | >Dapagliflozin >Placebo | Phase_III | Dapagliflozin DPPIV Inhib... | NCT00984867 |
| Active | Colorectal Cancer | >BMS-908662 >BMS-908662 >Cetuximab | Phase_I Phase_II | Safety and Efficacy Study... | NCT01086267 |
| Active | Renal Transplant | >Belatacept >Cyclosporine A or Tacrolimus | Phase_II Phase_III | A Study of BMS-224818 (Be... | NCT00402168 |
| Active | High Risk Stage III Melanoma | >ipilimumab >Placebo | Phase_III | Efficacy Study of Ipilimu... | NCT00636168 |
| Active | Stroke | >Clopidogrel >Clopidogrel placebo >Aspirin | Phase_IV | COMbination of Clopidogre... | NCT00814268 |
| Active | Solid Tumor Metastatic Colorectal Cancer | >dasatinib >bevacizumab >Oxaliplatin >Capecitabine | Phase_I Phase_II | XAD - Xelox (Capecitabine... | NCT00920868 |
| Active | Type 2 Diabetes Dyslipidemia | >BMS-816336 >BMS-816336 >BMS-816336 >BMS-816336 >BMS-816336 >Placebo | Phase_I | Safety Study of BMS-81633... | NCT00979368 |
| Active | HIV Infections | >Zalcitabine >Didanosine | A Prospective, Randomized... | NCT00000969 | |
| Active | Endometrial Cancer | >Cetuximab | Phase_II | Cetuximab in Patients Wit... | NCT00392769 |
| Active | Head and Neck Cancer | >Cetuximab | Phase_II | Cetuximab (ERBITUX®) Add... | NCT00468169 |
| Active | Atrial Fibrillation | >Apixaban >Acetylsalicylic Acid (ASA) | Phase_III | A Phase III Study of Apix... | NCT00496769 |
| Active | Breast Cancer | >Paclitaxel >Vinorelbine >Trastuzumab >Filgrastim | Phase_I Phase_II | Navelbine, Taxol, Hercept... | NCT00041470 |
| Active | Metastatic Prostate Cancer | >Dasatinib + Docetaxel | Phase_I Phase_II | Study of Dasatinib and Do... | NCT00439270 |
| Active | Breast Cancer | >Dasatinib and Paclitaxel | Phase_I Phase_II | Dasatinib In Combination ... | NCT00820170 |
| Active | Hepatitis C Infection | >BMS-790052 >BMS-790052 >BMS-790052 >Placebo >Peginterferon alpha-2a >ribavirin | Phase_II | Safety and Efficacy of BM... | NCT00874770 |
| Active | Hepatic Insufficiency | >BMS-650032 | Phase_I | Hepatic Impaired Subjects... | NCT01019070 |
| Active | Cancer | >celecoxib | Phase_I Phase_II | Radiosensitization With C... | NCT00581971 |
| Active | Hepato Cellular Carcinoma (HCC) | >Brivanib >Placebo >Sorafenib >Placebo | Phase_III | First Line Hepato Cellula... | NCT00858871 |
| Active | Pediatric HIV HIV Infections | >Boosted Atazanavir | Phase_IV | Equivalence of Boosted At... | NCT00940771 |
| Active | Coronary Artery Disease Coronary Artery Bypass Grafting | >Aspirin >Clopidogrel | Phase_III | Preoperative Aspirin and ... | NCT00330772 |
| Active | Hepatitis B, Chronic | >Entecavir >Entecavir + Tenofovir | Phase_III | Entecavir Plus Tenofovir ... | NCT00410072 |
| Active | Type 2 Diabetes | >Dapagliflozin >Dapagliflozin >Dapagliflozin >Dapagliflozin >Dapagliflozin >Dapagliflozin >Dapagliflozin matching Placebo >Metformin >Metformin (as needed for rescue based on protocol specific criteria) | Phase_III | A Phase III Study of BMS-... | NCT00528372 |
| Active | Metastatic Breast Cancer | >Dasatinib + Letrozole >Letrozole | Phase_II | Randomized Phase II Trial... | NCT00696072 |
| Active | Hodgkin's Disease | >Rituximab >ABVD | Phase_II | Study Comparing Rituximab... | NCT00797472 |
| Active | Juvenile Rheumatoid Arthritis | >Abatacept >Placebo >Abatacept | Phase_III | BMS-188667 in Children an... | NCT00095173 |
| Active | Advanced Breast Cancer | >Dasatinib + Capecitabine | Phase_I | Phase I Study of Dasatini... | NCT00452673 |
| Active | Organ Transplantation | >Belatacept >Belatacept >Alemtuzumab >donor bone marrow | Phase_II | Belatacept Post Depletion... | NCT00565773 |
| Active | Rectal Cancer | >FOLFOX4 >Cetuximab | Phase_II | Phase II Trial of Neoadju... | NCT00580073 |
| Active | Blood Platelets Clopidogrel | >clopidogrel + aspirin >placebo + aspirin | PACT (Platelet Activity A... | NCT00619073 | |
| Active | Myeloid Leukemia, Chronic, Chronic-Phase | >dasatinib >dasatinib >dasatinib >dasatinib | Phase_III | Chronic Myelogenous Leuke... | NCT00123474 |
| Active | Autism Asperger's Disorder Pervasive Developmental Disorder | >Aripiprazole | Phase_II | An Open-Label Trial of Ar... | NCT00308074 |
| Active | Chronic Hepatitis B | >entecavir >Other anti-HBV medication | Study of Entecavir in Pat... | NCT00388674 | |
| Active | Malignant Pleural Mesothelioma | >Dasatinib | Phase_I | Dasatinib in Resectable M... | NCT00652574 |
| Active | Melanoma | >AntiCD137 >AntiCD137 >AntiCD137 >AntiCD137 >AntiCD137 >Ipilimumab | Phase_I | Combination of Anti-CD137... | NCT00803374 |
| Active | Small Cell Lung Carcinoma | >BMS-833923 >Carboplatin >Etoposide | Phase_I | A Study of BMS-833923 Wit... | NCT00927875 |
| Active | Hepatitis C Infection | >BMS-790052 >BMS-790052 >Placebo >Peginterferon alfa-2a >Ribavirin | Phase_II | Safety and Efficacy of BM... | NCT01017575 |
| Active | Breast Cancer | >Dasatinib | Phase_II | Personalized Treatment Se... | NCT00780676 |
| Active | Unspecified Adult Solid Tumor, Protocol Specific | >Ixabepilone >Sunitinib >Angiogenesis Biomarker Analysis >Pharmacokinetic Design | Phase_I | Ixabepilone and Sunitinib... | NCT00884676 |
| Active | Type 2 Diabetes | >Saxagliptin >Metformin XR >Metformin XR | Phase_III | An 18 Week Efficacy and S... | NCT00960076 |
| Active | Renal Transplantation | >CsA >Belatacept LI >Belatacept MI | Phase_III | Study of Belatacept in Su... | NCT00114777 |
| Active | Bipolar Disorder | >abilify | Phase_III | Study of Aripiprazole (Ab... | NCT00194077 |
| Active | Systemic Lupus Erythematosus | >steroids (prednisone or prednisolone) + MMF >abatacept >abatacept | Phase_II Phase_III | Efficacy and Safety Study... | NCT00430677 |
| Active | Non-small Cell Lung Cancer (NSCLC) | >Paclitaxel >Carboplatin >CT-322 >Bevacizumab >Bevacizumab placebo (ie saline solution) | Phase_II | Ph II of a Novel Anti-ang... | NCT00850577 |
| Active | Type 2 Diabetes Mellitus Cardiovascular Disease Inadequate Glycaemic Control | >Dapagliflozin >Placebo | Phase_III | Efficacy and Safety in Pa... | NCT01042977 |
| Active | Colorectal Cancer Neoplasm Metastasis | >Cetuximab >Oxaliplatin >Capecitabine | Phase_II | Cetuximab, Capecitabine a... | NCT00444678 |
| Active | Metastatic Breast Cancer | >ixabepilone | Phase_II | Phase II Study of Ixabepi... | NCT00627978 |
| Active | Type 2 Diabetes | >Dapagliflozin >Dapagliflozin >Placebo | Phase_III | Add-on to Thiazolidinedio... | NCT00683878 |
| Active | Type 2 Diabetes | >Saxagliptin plus metformin IR >Placebo plus metformin IR | Phase_III | Efficacy and Safety Study... | NCT00885378 |
| Active | Healthy Volunteers | >Dapagliflozin >Dapagliflozin | Phase_I | A Study to to Assess the ... | NCT01072578 |
| Active | Type 2 Diabetes | >Dapagliflozin >placebo | Phase_III | A Phase III Study of BMS-... | NCT00528879 |
| Active | Acquired Immune Deficiency Syndrome AIDS Human Immunodeficiency Virus HIV Infections | >Raltegravir >Atazanavir >Standard treatment regimen | Pilot Study of a Raltegra... | NCT00814879 | |
| Active | Type 2 Diabetes Mellitus | >Dapagliflozin >Placebo | Phase_II | Effects of Dapagliflozin ... | NCT00831779 |
| Active | Type 2 Diabetes | >Saxagliptin >Placebo | Phase_III | Evaluate Saxagliptin in A... | NCT00918879 |
| Active | Hepatitis C | >Midazolam >BMS-791325 | Phase_I | Study to Assess the Effec... | NCT00996879 |
| Active | Alzheimer Disease | >BMS-708163 >Rifampin >Rifampin | Phase_I | Drug-Drug Interaction Stu... | NCT01002079 |
| Active | Breast Neoplasms Breast Cancer | >Vinflunine >Herceptin | Phase_II | Vinflunine Plus Trastuzum... | NCT00284180 |
| Active | Prostate Cancer | >dasatinib | Phase_II | Phase II Study of Dasatin... | NCT00385580 |
| Active | Type 2 Diabetes Mellitus Cardiovascular Disease Hypertension Inadequate Glycaemic Control | >Dapagliflozin >Placebo | Phase_III | Efficacy and Safety in Pa... | NCT01031680 |
| Active | Diabetes Mellitus, Type 2 | >Observational Study | Risk of Cardiovascular Ev... | NCT01086280 | |
| Active | Breast Cancer | >Doxorubicin >Cyclophosphamide >Ixabepilone (Ixempra) >Paclitaxel (Taxol) | Phase_III | A Randomized Trial of Ixe... | NCT00789581 |
| Active | Human Immunodeficiency Virus Type 1 (HIV-1) HIV Infections | >Voriconazole >Atazanavir >Ritonavir >Voriconazole | Phase_I | Drug Interactions Between... | NCT00833482 |
| Active | Advanced Solid Cancers Metastatic Cancer | >Cdc7-inhibitor | Phase_I Phase_II | A Study of BMS-863233 in ... | NCT00886782 |
| Active | Carcinoma, Non-Small-Cell Lung | >Carboplatin >Paclitaxel >Vinorelbine | Phase_II | Study for Patients With N... | NCT00168883 |
| Active | Cancer of Head and Neck | >Erbitux, Paclitaxel & Carboplatin >Radiation | Phase_II | Evaluation of Cetuximab (... | NCT00343083 |
| Active | Cancer | >BMS-690514 / FOLFIRI >BMS-690514 / FOLFOX | Phase_I | Combination Trial of BMS-... | NCT00479583 |
| Active | Head and Neck Cancer | >Cetuximab >Dasatinib >Cisplatin >Radiation Therapy | Phase_I Phase_II | A Study of Dasatinib, Cet... | NCT00882583 |
| Active | Dyslipidemia | >BMS-770767 >BMS-770767 >BMS-770767 >BMS-770767 >Placebo | Phase_II | Safety Study of BMS-77076... | NCT01058083 |
| Active | Unspecified Childhood Solid Tumor, Protocol Specific | >carboplatin >irinotecan hydrochloride | Phase_I | Carboplatin and Irinoteca... | NCT00024284 |
| Active | Chronic Hepatitis B | >Entecavir >Lamivudine Placebo >Lamivudine >Entecavir Placebo | Phase_IV | A Study in Korea of Entec... | NCT00393484 |
| Active | Atrial Fibrillation Atrial Flutter | >warfarin >apixaban | Phase_III | Apixaban for the Preventi... | NCT00412984 |
| Active | Dilated Cardiomyopathy | >protein A immunoadsorption >pseudo-immunoadsorption | Phase_IV | Multicenter Study of Immu... | NCT00558584 |
| Active | Metastatic Colorectal Cancer (MCRC) | >Cetuximab >Irinotecan >Brivanib >Brivanib >Brivanib Placebo | Phase_I Phase_II | Phase I/II Combination Wi... | NCT00594984 |
| Active | Rheumatoid Arthritis (RA) | >Abatacept subcutaneous + placebo IV >Abatacept IV + placebo subcutaneous | Phase_III | Methotrexate-Inadequate R... | NCT00559585 |
| Active | Myelodysplastic Syndromes | >Dasatinib | Phase_II | Study of Oral Dasatinib i... | NCT00624585 |
| Active | Prostate Cancer | >Nilutamide >Dasatinib | Phase_II | Genomic Guided Therapy Wi... | NCT00918385 |
| Active | Leukemia Lymphoma | >Dasatinib (BMS-354825) | Phase_II | Therapy of Chronic Lympho... | NCT00364286 |
| Active | Cancer (Solid Tumors) | >BMS-690514 | Phase_I | A Phase I Study of BMS-69... | NCT00420186 |
| Active | Breast Cancer | >Ixabepilone >Trastuzumab >Carboplatin | Phase_II | Neoadjuvant Ixabepilone/C... | NCT00821886 |
| Active | Myeloid Leukemia, Chronic, Accelerated Phase Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | >dasatinib >dasatinib >dasatinib >dasatinib | Phase_II | Advanced Chronic Myelogen... | NCT00123487 |
| Active | Metastatic Breast Cancer | >Erbitux >Irinotecan >Carboplatin | Phase_II | PhII ICb With/Without Erb... | NCT00248287 |
| Active | Hepatitis B, Chronic | >Entecavir >Adefovir Switching to Entecavir | Phase_IV | Suboptimal Responders to ... | NCT00718887 |
| Active | Type 2 Diabetes | >Metformin >Suphonylurea >Saxagliptin | Phase_III | 52-Week Add-on to Metform... | NCT00575588 |
| Active | Locally Advanced Breast Cancer Metastatic Breast Cancer | >Ixabepilone + lapatinib >Ixabepilone + lapatinib + capecitabine | Phase_I | Phase I Study of Ixabepil... | NCT00634088 |
| Active | Non-small Cell Lung Cancer | >Ixabepilone >Carboplatin >Bevacizumab | Phase_II | Ixabepilone and Carboplat... | NCT00741988 |
| Active | Type 2 Diabetes | >Saxagliptin >Placebo | Phase_III | Safety and Efficacy Study... | NCT00757588 |
| Active | Chronic Lymphocytic Leukemia | >Dasatinib and Rituximab >Dasatinib and Rituximab | Phase_I Phase_II | A Study of Dasatinib + Ri... | NCT00949988 |
| Active | Leukemia | >Dasatinib >Imatinib | Phase_II | START Rollover Study | NCT00982488 |
| Active | Esophageal Neoplasm | >UFT (Tegafur/Uracil) | Phase_II | A Phase II Study of Pacli... | NCT00037089 |
| Active | Esophageal Cancer Gastric Cancer Neoplasm Metastasis | >Cetuximab | Phase_II | Use of Cetuximab for Unre... | NCT00130689 |
| Active | Breast Cancer | >FAC >paclitaxel | Phase_III | Fluorouracil Plus Doxorub... | NCT00129389 |
| Active | HIV Infections Hepatitis B Virus | Phase_IV | Multi-sponsor Registry to... | NCT00404989 | |
| Active | Rheumatoid Arthritis | >Abatacept | Phase_III | A Phase III Study of Abat... | NCT00484289 |
| Active | Advanced Non-Small Cell Lung Cancer Transitional Cell Carcinoma Soft Tissue Sarcoma Gastric/Esophageal Adenocarcinoma Pancreatic Cancer Including Ampulla of Vater | >brivanib >Placebo | Phase_II | Phase II Study of Brivani... | NCT00633789 |
| Active | Hedgehog Pathway Smoothened Basal Cell Carcinoma (BCC) Basal Cell Nevoid Syndrome (BCNS) | >BMS-833923 (XL139) | Phase_I | A Phase 1 Study of BMS-83... | NCT00670189 |
| Active | HIV | >Atazanavir >Raltegravir >Atazanavir >Ritonavir >TDF/FTC | Phase_II | Phase IIB Pilot of Atazan... | NCT00768989 |
| Active | Glioblastoma | >Dasatinib >Lomustine | Phase_I Phase_II | Study of CCNU (Lomustine)... | NCT00948389 |
| Active | Thymoma Clinical Masaoka Stage III or IVA | >Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide | Phase_II | Chemotherapy Plus Cetuxim... | NCT01025089 |
| Active | Schizophrenia | >Aripiprazole >Olanzapine >Haloperidol | Phase_IV | Pragmatic RCT Comparing A... | NCT01052389 |
| Active | Autistic Disorder Asperger Syndrome PDD, NOS | >aripiprazole | Phase_II | Study of Aripiprazole to ... | NCT00619190 |
| Active | Type 2 Diabetes | >CCR2 Antagonist >Placebo | Phase_II | Proof of Confidence Study... | NCT00699790 |
| Active | Refractory Hematologic Cancer | >Cdc7-inhibitor (BMS-863233) >Cdc7-inhibitor (BMS-863233) | Phase_I Phase_II | A Study of BMS-863233 in ... | NCT00838890 |
| Active | Alzheimer's Disease | >BMS-708163 >Placebo | Phase_II | A Multicenter, Double Bli... | NCT00890890 |
| Active | HIV | >Atazanavir >Atazanavir/Ritonavir >Tenofovir/Emtricitabine | Phase_III | Roll-Over Protocol To Pro... | NCT01003990 |
| Active | Type 2 Diabetes Mellitus | >Saxagliptin >Metformin | Phase_IV | Efficacy and Tolerability... | NCT01006590 |
| Active | Myocardial Infarction Coronary Artery Disease | >coronary balloon-angioplasty with stenting | The Viability-Guided Angi... | NCT00149591 | |
| Active | Hepatitis B, Chronic | >Entecavir | Phase_I Phase_II | A Study of Entecavir in P... | NCT00423891 |
| Active | Multiple Myeloma | >Dasatinib + Lenalidomide + Dexamethasone | Phase_I | Dasatinib in Combination ... | NCT00560391 |
| Active | Refractory Solid Tumors Pancreatic Adenocarcinoma | >gemcitabine >dasatinib >gemcitabine >dasatinib | Phase_I Phase_II | A Phase I/Expansion Study... | NCT00598091 |
| Active | Advanced Melanoma | >Ipilimumab >Carboplatin >Paclitaxel >Dacarbazine | Phase_I | DDI - 3 Arm - Carboplatin... | NCT00796991 |
| Active | Healthy Volunteers | >Dapagliflozin/Metformin >Dapagliflozin >Metformin >Dapagliflozin/Metformin >Dapagliflozin >Metformin | Phase_I | A Study Comparing the Amo... | NCT01055691 |
| Active | Prostate Cancer | >Paclitaxel >Estramustine >Carboplatin | Phase_II | Weekly Paclitaxel, Low-Do... | NCT00193193 |
| Active | Rheumatoid Arthritis | >Abatacept or Placebo (both as IV & SC Solution) >Abatacept or Placebo (both as IV & SC Solution) >Abatacept or Placebo (both as IV & SC solution) >Abatacept or Placebo (both as IV & SC solution) >Abatacept or Placebo (both as IV | Phase_I Phase_II | Study to Assess Steady-St... | NCT00254293 |
| Active | HIV Infections | >Efavirenz (EFV) + Didanosine (ddI) + Emtricitabine (FTC) | Phase_I Phase_II | Safety, Tolerability and ... | NCT00364793 |
| Active | Acute Lymphoblastic Leukemia Leukemia | >Cyclophosphamide >Vincristine >Doxorubicin >Dexamethasone >Dasatinib | Phase_II | Hyper-CVAD Plus Dasatinib... | NCT00390793 |
| Active | HIV Infections Coronary Atherosclerosis | Subclinical Atheroscleros... | NCT00455793 | ||
| Active | Bladder Cancer | >Gemcitabine, Cisplatin >Gemcitabine, Cisplatin and Cetuximab | Phase_II | Study of Gemcitabine and ... | NCT00645593 |
| Active | Venous Thrombosis | >Apixaban >Placebo | Phase_III | Efficacy and Safety Study... | NCT00633893 |
| Active | Diabetes Mellitus, Type 2 | >Observational Study | Risk of Acute Kidney Inju... | NCT01086293 | |
| Active | Coronary Heart Disease Dyslipidemia Diabetes Mellitus, Non-Insulin-Dependent HIV Infection | >Provision of computer generated CHD risk profiles | Phase_IV | Cardiovascular Risk Facto... | NCT00264394 |
| Active | Type 2 Diabetes | Evaluation of Diabetes Ca... | NCT00979394 | ||
| Active | Alzheimer Disease | >galantamine >galantamine >BMS-708163 | Phase_I | Drug-Drug Interaction to ... | NCT01039194 |
| Active | Urticaria | >abatacept (Orencia ®) | Phase_I Phase_II | Study to Evaluate The Saf... | NCT00886795 |
| Active | Type 2 Diabetes Mellitus | >Dapagliflozin >Placebo >Hydrochlorothiazide | Phase_II | Effects of Dapagliflozin ... | NCT00976495 |
| Active | Chronic Hepatitis C | >BMS-790052 >BMS-650032 >pegylated-interferon-α >ribavirin | Phase_II | Study to Determine the Ef... | NCT01012895 |
| Active | Rheumatoid Arthritis | >Observational Study | Safety Study of Abatacept... | NCT01094795 | |
| Active | Bipolar Disorder | >Aripiprazole >Divalproex ER | Phase_IV | 12- Week Open Label Treat... | NCT00223496 |
| Active | Cancer | >Ixabepilone | Phase_I | A Phase I Study of Oral I... | NCT00422097 |
| Active | Rheumatoid Arthritis | >Abatacept >Placebo | Phase_III | Phase IIIB Subcutaneous M... | NCT00533897 |
| Active | Prostatic Neoplasms | >placebo + docetaxel/prednisone >dasatinib + docetaxel/prednisone | Phase_III | Randomized Study Comparin... | NCT00744497 |
| Active | Advanced Solid Tumors Metastatic Solid Tumors | >BMS-754807 >Paclitaxel >Carboplatin | Phase_I | Multiple Dose Study In Ca... | NCT00793897 |
| Active | Acute Coronary Syndrome | >Apixaban >Apixaban >Placebo | Phase_II | A Study to Evaluate the S... | NCT00852397 |
| Active | Chronic Myeloid Leukemia | >Dasatinib (Sprycel) | Phase_II | Efficacy and Safety Study... | NCT00895297 |
| Active | Gastric Cancer Esophageal Cancer | >oxaliplatin, capecitabine | Phase_II | Study of Oxaliplatin and ... | NCT00183898 |
| Active | Schizophrenia Schizoaffective Disorder Schizophreniform Disorder Mood Disorders | >aripiprazole | Phase_IV | Body Mass Index (BMI) and... | NCT00312598 |
| Active | Type 2 Diabetes Mellitus | >Dapagliflozin >Metformin XR >Metformin XR | Phase_III | Study of Dapagliflozin in... | NCT00859898 |
| Active | Acute HIV Infection HIV Infections | >Atripla | Phase_IV | Treatment of Acute HIV Wi... | NCT00924898 |
| Active | Rheumatoid Arthritis, NOS | >Abatacept >placebo | Phase_III | A Phase IIIb Study of BMS... | NCT00420199 |
| Active | Schizophrenia Sensory Gating | >Aripiprzole | Remediation of Schizophre... | NCT00567099 | |
| Active | Glioblastoma Gliosarcoma | >Erlotinib and Dasatinib | Phase_I | Ph I Dasatinib + Erlotini... | NCT00609999 |
| Active | Depressive Disorder, Major | The Effect of Patient Cos... | NCT01141400 | ||
| Active | Chronic Hepatitis C Virus Genotype 1 | >BMS-824393 >BMS-824393 >BMS-824393 >Placebo >Peginterferon Alpha-2a >Ribavirin | Phase_II | A Study of BMS-824393 in ... | NCT01142700 |
| Active | Coronary Graft Patency | >clopidogrel >sugar pill | Phase_IV | Aspirin and Plavix Follow... | NCT01158703 |
| Active | Carcinoma, Hepatocellular | >Brivanib >Placebo | Phase_III | Comparison of Brivanib an... | NCT01108705 |
| Active | Metastatic Melanoma | >Ipilimumab >Temozolomide | Phase_II | Ipilimumab + Temozolomide... | NCT01119508 |
| Active | Atrial Fibrillation | >BMS-914832 >Diltiazem | Phase_I | Effect of Diltiazem on Ph... | NCT01211808 |
| Active | Non-small Cell Lung Cancer | >Ipilimumab >Ipilimumab >Paclitaxel >Carboplatin | Phase_I | Japanese Study of Ipilimu... | NCT01165216 |
| Active | Rheumatoid Arthritis | Observational Real-world ... | NCT01166620 | ||
| Active | Atrial Fibrillation | >metoprolol >BMS-914392 | Phase_I | Effect of BMS-914392 on P... | NCT01211821 |
| Active | Dyslipidemia | >BMS-823778 >BMS-823778 >BMS-823778 >Placebo | Phase_II | Safety Study of BMS-82377... | NCT01112423 |
| Active | Lung Neoplasms Carcinoma Cancer of the Lung Non-Small-Cell Lung Carcinoma | >Cetuximab >Cisplatin >Vinorelbine | Phase_II | Safety Study of Cetuximab... | NCT01109524 |
| Active | Rheumatoid Arthritis | >Abatacept >Methotrexate >Abatacept Placebo >Methotrexate Placebo | Phase_III | Efficacy and Safety of Ab... | NCT01142726 |
| Active | Healthy | >PF-04620110 >Placebo | Phase_I | A Multiple Dose Study Of ... | NCT01146327 |
| Active | Venous Thromboembolism | >Apixaban >Apixaban >Apixaban >Apixaban >Apixaban | Phase_I | Multiple-Dose Study Apixa... | NCT01195727 |
| Active | HIV | >Atazanavir >Atazanavir >Ritonavir >Ritonavir >Tenofovir >Tenofovir >Nucleoside Reverse Transcriptase Inhibitor (NRTI) >Nucleoside Reverse Transcriptase Inhibitor (NRTI) >Famotidine >Famotidine | Phase_IV | Drug-Drug Interaction (DD... | NCT01232127 |
| Active | Type 2 Diabetes | >BMS-820132 >BMS-820132 >BMS-820132 >BMS-820132 >BMS-820132 >BMS-820132 >BMS-820132 >BMS-820132 >BMS-820132 >Placebo | Phase_I | Single Ascending Dose Stu... | NCT01105429 |
| Active | Drug Interaction | >omeprazole and pantoprazole | Phase_I | PPI and Clopidogrel Respo... | NCT01170533 |
| Active | Chronic Coronary Occlusion Vascular Disease Myocardial Ischemia Coronary Artery Stenosis Coronary Disease Coronary Artery Disease Coronary Restenosis | >Thienopyridine (clopidogrel or prasugrel) | Phase_IV | XIENCE V® USA Dual Antip... | NCT01106534 |
| Active | HIV | Study on Long Term Outcom... | NCT01236235 | ||
| Active | Rheumatoid Arthritis | >Abatacept | Phase_I | Pharmacokinetic Study to ... | NCT01221636 |
| Active | Rheumatoid Arthritis | Changes in the Use of Opi... | NCT01137838 | ||
| Active | Breast Cancer | >Cetuximab >Ixabepilone | Phase_II | Neo-Adjuvant Study in Tri... | NCT01097642 |
| Active | Major Depression | >Placebo >BMS-866949 >BMS-866949 >BMS-866949 >BMS-866949 >BMS-866949 >BMS-866949 >BMS-866949 | Phase_I | Safety and Pharmacology S... | NCT01124344 |
| Active | Non-Small-Cell Lung Carcinoma | >BMS-690514 | Phase_II | Trial of BMS-690514 in No... | NCT01167244 |
| Active | Head Squamous Cell Carcinoma Neck Squamous Cell Carcinoma | >Cetuximab >Surgery >Post-surgical radiation >Cisplatin or carboplatin | Phase_II | ERBITUX® Followed by Adj... | NCT01218048 |
| Active | Myocardial Infarction Percutaneous Coronary Intervention | >Clopidogrel | Phase_II | Escalating Clopidogrel by... | NCT01235351 |
| Active | Cancer | >BMS-911543 | Phase_I Phase_II | Multiple Ascending Dose o... | NCT01236352 |
| Active | Type 2 Diabetes | >Dapagliflozin >Dapagliflozin >Metformin >Dapagliflozin Placebo | Phase_III | A Phase III Study of BMS-... | NCT01095653 |
| Active | Type 2 Diabetes | >Saxagliptin >Placebo | Phase_III | Saxagliptin Triple Oral T... | NCT01128153 |
| Active | Diabetes Mellitus, Type 2 | >BMS-823778 >BMS-823778 >BMS-823778 >Placebo | Phase_II | Safety Study of BMS-82377... | NCT01111955 |
| Active | HIV Infection Mitochondrial Dysfunction | >Atazanavir/ritonavir >Efavirenz | Phase_IV | Switching From Efavirenz ... | NCT01194856 |
| Active | Acute Myeloid Leukemia | >MDX-1338/BMS-936564 (Anti-CXCR4) >MDX-1338/BMS-936564 (Anti-CXCR4) | Phase_I | First in Human Study to D... | NCT01120457 |
| Active | Diabetes Mellitus, Type 2 | Risk Factors for Low Lymp... | NCT01192659 | ||
| Active | Hepatitis C Virus | >BMS-791325 >BMS-791325 >Placebo >Peg-interferon alfa-2a >Ribavirin | Phase_II | Ph IIA Study (SOC +/- NS5... | NCT01193361 |
| Active | Hepatitis C Virus | >BMS-790052 >BMS-790052 >Placebo >peginterferon alfa-2a >ribavirin | Phase_II | Study of the Anti-HCV Dru... | NCT01170962 |
| Active | Type 2 Diabetes | >Dapagliflozin >Dapagliflozin >Placebo | Phase_III | A Study of BMS-512148 (Da... | NCT01195662 |
| Active | Hepatitis B Virus | >pegIFN >pegIFN >pegIFNα-2a | Phase_II | Dose Ranging Study of Peg... | NCT01204762 |
| Active | Type 2 Diabetes | >Dapagliflozin >Dapagliflozin >Metformin >Dapagliflozin Placebo >Pioglitazone | Phase_III | A Phase III Study of BMS-... | NCT01095666 |
| Active | Type 2 Diabetes Mellitus | >Dapagliflozin | Phase_I | Characterization of the K... | NCT01165268 |
| Active | Autistic Disorder | >Aripiprazole >Placebo | Phase_IV | OPT - Phase IV Long Term ... | NCT01227668 |
| Active | Neoplasms | >BMS-844203 (CT-322) | Phase_I | Japanese Phase 1 Study of... | NCT01146171 |
| Active | Prostate Cancer | >Leuprolide Acetate >Ipilimumab >Radical Prostatectomy | Phase_II | Neoadjuvant Ipilimumab in... | NCT01194271 |
| Active | Diabetes | >Insulin, glucose and staple isotopes | Phase_I | Experimental Study to Val... | NCT01152372 |
| Active | Breast Cancer | >BMS-754807 >letrozole | Phase_II | Study of BMS-754807 Combi... | NCT01225172 |
| Active | Type 2 Diabetes | >Dapagliflozin >Dapagliflozin >Dapagliflozin >Placebo | Phase_III | A Study of BMS-512148 (Da... | NCT01137474 |
| Active | Type 2 Diabetes | >Saxagliptin >Placebo (Saxagliptin) >Metformin IR >Placebo (Metformin) >Metformin (Active Rescue) | Phase_III | Study to Evaluate the Eff... | NCT01204775 |
| Active | Leukemia | >Dasatinib >BMS-833923 | Phase_I Phase_II | Dasatinib Combo With SMO ... | NCT01218477 |
| Active | Thrombosis | >No Intervention | Phase_II | Pediatric Catheter-relate... | NCT01137578 |
| Active | CML-CP: Chronic Myeloid Leukemia in Chronic Phase | >Imatinib | Treatment With Second Gen... | NCT01188278 | |
| Active | HIV Infections | >Atazanavir >Ritonavir | Phase_III | PRINCE: Study of Atazanav... | NCT01099579 |
| Active | Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma | >dasatinib >Rituximab >fludarabine | Phase_II | Dasatinib With Fludarabin... | NCT01173679 |
| Active | Diabetes | >BMS-903452 >BMS-903452 >BMS-903452 >BMS-903452 >BMS-903452 >BMS-903452 >BMS-903452 >BMS-903452 >Placebo >Placebo | Phase_I | Safety Study of BMS-90345... | NCT01240980 |
| Active | Type 2 Diabetes Mellitus | >Saxagliptin >Placebo | Phase_IV | Does Saxagliptin Reduce t... | NCT01107886 |
| Active | Depressive Disorder, Major | Outcomes in MEasurement-B... | NCT01141387 | ||
| Active | Chronic Myeloid Leukemia | >Stem Cell and Mutational Assay | A Study Investigating the... | NCT01215487 | |
| Active | Hepatitis C Virus | >BMS-790052 >BMS-790052 >Placebo >peg-interferon alfa-2a >ribavirin | Phase_II | Study of BMS-790052 Add-O... | NCT01125189 |
| Active | Type 2 Diabetes | >dapagliflozin >dapagliflozin >dapagliflozin >metformin >placebo | Phase_III | Evaluation of Dapaglifloz... | NCT01217892 |
| Active | Multiple Myeloma | >BMS-901608 (Elotuzumab) | Phase_I | Japanese Study of BMS-901... | NCT01241292 |
| Active | Rheumatoid Arthritis | Economic Burden in Adult ... | NCT01136694 | ||
| Active | Relapsed or Refractory Multiple Myeloma | >Lenalidomide >Dexamethasone >Dexamethasone (Oral) >Dexamethasone (IV) >Elotuzumab | Phase_III | Study of Lenalidomide and... | NCT01239797 |
| Active | Hepatitis C Virus | >Placebo >BMS-790052 >BMS-790052 >Pegylated-interferon alfa 2a >Pegylated-interferon alfa 2a >Pegylated-interferon alfa 2a >Ribavirin >Ribavirin >Ribavirin | Phase_II | Study in Genotype 2/3 Sub... | NCT01257204 |
| Active | Lung Cancer - Non Small Cell | >Ipilimumab >Placebo >Paclitaxel >Carboplatin | Phase_III | Trial in Squamous Non Sma... | NCT01285609 |
| Active | Colitis, Ulcerative | >Placebo >Placebo >Anti-IP-10 Antibody >Anti-IP-10 Antibody >Anti-IP-10 Antibody >Anti-IP-10 Antibody >Anti-IP-10 Antibody >Anti-IP-10 Antibody | Phase_II | Induction and Maintenance... | NCT01294410 |
| Active | Type 2 Diabetes | >Dapagliflozin >Dapagliflozin >placebo | Phase_III | Evaluation of Efficacy an... | NCT01257412 |
| Active | Depressive Disorder, Major | Retrospective Database St... | NCT01284218 | ||
| Active | Diabetes Mellitus, Type 2 High Blood Sugar | >Dapagliflozin >Dapagliflozin >Placebo | Phase_III | Evaluate Efficacy and Saf... | NCT01294423 |
| Active | Diabetes Mellitus, Type 2 High Blood Sugar | >Dapagliflozin | Phase_III | Evaluate Safety as Mono o... | NCT01294436 |
| Active | Postherpetic Neuralgia | >BMS-954561 >BMS-954561 >Placebo | Phase_II | Crossover Post-herpetic N... | NCT01305538 |
| Active | Diabetes Mellitus Type 2 Severe Hyperglycemia. | >Glipizide XL >Saxagliptin + Metformin XR >Metformin XR | Phase_IV | Outpatient Discharge Ther... | NCT01267448 |
| Active | Chronic Myeloid Leukemia | Studying First Line Treat... | NCT01244750 | ||
| Active | Diabetes Mellitus, Non-Insulin-Dependent | >Saxagliptin >Metformin XR >Saxagliptin/Metformin XR FDC | Phase_I | BE Study of the Fixed Dos... | NCT01305551 |
| Active | Uveitis | >Abatacept | Phase_II | Abatacept in the Treatmen... | NCT01279954 |
| Active | Cancer | >BMS-906024 | Phase_I | Study to Evaluate the Saf... | NCT01292655 |
| Active | Melanoma | >BMS-908662 >BMS-908662 >Ipilimumab >Ipilimumab | Phase_I | Safety and Efficacy Study... | NCT01245556 |
| Active | Relapsing Polychondritis | >Abatacept | Phase_I | Study on the Safety of Ab... | NCT01272856 |
| Active | Prostate | >Abiraterone Acetate >Prednisone >Sunitinib >Dasatinib | Phase_II | Maximum Androgen Depletio... | NCT01254864 |
| Active | Use of Atypical Antipsychotics During Pregnancy | National Pregnancy Regist... | NCT01246765 | ||
| Active | Rheumatoid Arthritis | Safety Study of Abatacept... | NCT01247766 | ||
| Active | Diabetes Mellitus, Type 2 | >Placebo >Placebo >BMS-820132 >BMS-820132 >BMS-820132 >BMS-820132 >BMS-820132 >BMS-820132 | Phase_I | Multiple Ascending Dose S... | NCT01290575 |
| Active | Hepatitis C | HCV (Hepatitis C Virus) V... | NCT01293279 | ||
| Active | Diabetes Mellitus, Type 2 | Screening Epidemiological... | NCT01275794 | ||
| Active | Hepatitis B, Chronic | Persistence, Adherence an... | NCT01356901 | ||
| Active | Non-small Cell Lung Cancer | >BMS-936558 (Anti-PD1) >BMS-936558 (Anti-PD1) >BMS-936558 (Anti-PD1) >Gemcitabine >Cisplatin >Pemetrexed >Paclitaxel >Carboplatin | Phase_I | Multi-arm Study of BMS-93... | NCT01454102 |
| Active | Rheumatoid Arthritis | >Abatacept (BMS-188667) | Phase_I | Pharmacokinetic Study to ... | NCT01439204 |
| Active | Hepatitis C | Three-year Follow-up Stud... | NCT01492504 | ||
| Active | HIV-1 | Korean Post-marketing Sur... | NCT01450605 | ||
| Active | Cancer | >BMS-833923 (XL139) | Phase_I | Phase 1 Multiple Ascendin... | NCT01413906 |
| Active | HIV Infection | Post-marketing Safety Sur... | NCT01389310 | ||
| Active | Cancer - Solid Tumors | >BMS-663513 (Anti-CD137) >BMS-663513 (Anti-CD137) >BMS-663513 (Anti-CD137) | Phase_I | Safety, Tolerability, Pha... | NCT01471210 |
| Active | Atrial Fibrillation | >BMS-914392 >BMS-914392 >BMS-914392 >Placebo | Phase_II | Pacemaker Holter Assessme... | NCT01356914 |
| Active | Melanoma | >Ipilimumab, Melphalan and Dactinomycin | Phase_II | Addition of Ipilimumab (M... | NCT01323517 |
| Active | Lymphoblastic Leukemia, Acute T-cell Precursor T-Cell Lymphoblastic Lymphoma | >BMS-906024 | Phase_I | Study to Evaluate the Saf... | NCT01363817 |
| Active | End-Stage Renal Disease | >Belatacept | Belatacept in Renal Trans... | NCT01496417 | |
| Active | HIV | Comparative Tolerability ... | NCT01450618 | ||
| Active | Squamous Cell Carcinoma Of The Head And Neck | >Cetuximab >Dasatinib | Phase_II | Cetuximab and Dasatinib i... | NCT01488318 |
| Active | Renal Cell Carcinoma | >BMS-936558 (Anti-PD-1) >BMS-936558 (Anti-PD-1) >BMS-936558 (Anti-PD-1) | Phase_I | Phase I Biomarker Study (... | NCT01358721 |
| Active | Diabetic Peripheral Neuropathic Pain | >BMS-954561 >Pregabalin >BMS-954561 >Placebo matching BMS-954561 >Placebo matching Pregabalin | Phase_II | Diabetic Peripheral Neuro... | NCT01314222 |
| Active | Hepatitis C | >BMS-790052 (NS5A Replication Complex Inhibitor) >Peg-Interferon Alfa-2a >Ribavirin | Phase_III | BMS-790052 Plus Peg-Inter... | NCT01389323 |
| Active | Kidney Transplantation | Belatacept in Renal Trans... | NCT01471223 | ||
| Active | Extensive Stage Small Cell Lung Cancer | >Ipilimumab | Phase_II | The Addition of Ipilimuma... | NCT01331525 |
| Active | Hepatitis C | >BMS-790052 (Daclatasvir) >Telaprevir >Peginterferon alfa-2a >Ribavirin | Phase_III | Study Comparing BMS-79005... | NCT01492426 |
| Active | HIV, Combination Therapy | >Atazanavir >Ritonavir (heat-stable) >Raltegravir >Tenofovir/Emtricitabine | Phase_IV | Atazanavir/Ritonavir (ATV... | NCT01332227 |
| Active | Renal Cell Carcinoma | >BMS-936558 >BMS-936558 >BMS-936558 | Phase_II | BMS-936558 (MDX-1106) In ... | NCT01354431 |
| Active | Hepatitis C | >Pegylated Interferon Lambda (pegIFNλ) >BMS-790052 (NS5A Inhibitor) >Ribavirin (RBV) >BMS-650032 (NS3 Protease Inhibitor) >Pegylated Interferon Alfa-2a (pegIFNα-2a) >Pegylated Interferon Lambda (pegIFNλ) | Phase_II | Safety Study of Pegylated... | NCT01309932 |
| Active | Premature Endothelial Dysfunction Rheumatoid Arthritis Healthy | Exploratory Trial to Eval... | NCT01499732 | ||
| Active | Human Immunodeficiency Virus-1 | >BMS-663068 >BMS-663068 >BMS-663068 >BMS-663068 >Raltegravir >Raltegravir >Tenofovir >Tenofovir >Ritonavir >Atazanavir | Phase_II | HIV Attachment Inhibitor ... | NCT01384734 |
| Active | Non-Hodgkin's Lymphoma Hodgkin Lymphoma Multiple Myeloma Chronic Myelogenous Leukemia | >BMS-936559 (Anti PD-L1) | Phase_I | Safety Study of Anti-Prog... | NCT01452334 |
| Active | Hepatitis C | >BMS-790052 (Daclatasvir) >BMS-650032 (Asunaprevir) | Phase_III | A Phase 3 Study in Combin... | NCT01497834 |
| Active | Diabetes Mellitus, Type 2 | Risk of Acute Kidney Inju... | NCT01377935 | ||
| Active | Breast Cancer | >dasatinib plus trastuzumab plus paclitaxel | Phase_I Phase_II | Dasatinib In Combination ... | NCT01306942 |
| Active | Migraine - Acute | >Placebo matching BMS-927711 >BMS-927711 >BMS-927711 >BMS-927711 >BMS-927711 >BMS-927711 >BMS-927711 >Sumatriptan | Phase_II | Dose Ranging Study of a D... | NCT01430442 |
| Active | Transplantation, Organ | Patterns of Use of Belata... | NCT01476943 | ||
| Active | Chronic Hepatitis C | >PSI-7977 >BMS-790052 >Ribavirin >Ribavirin >Ribavirin >BMS-790052 >PSI-7977 | Phase_II | Study to Determine the Sa... | NCT01359644 |
| Active | Hepatitis C | >BMS-790052 (NS5A Replication Complex Inhibitor) >Placebo matching BMS-790052 >Pegylated-interferon alfa 2a >Pegylated-interferon alfa 2a >Ribavirin >Ribavirin | Phase_III | Phase III BMS-790052 Add-... | NCT01448044 |
| Active | Depression | >Duloxetine >Placebo matching with BMS-820836 >BMS-820836 >Duloxetine >Placebo matching with Duloxetine | Phase_II | Efficacy and Safety of Fl... | NCT01309945 |
| Active | Leukemia | >Dasatinib >Decitabine >Decitabine | Phase_I Phase_II | Phase I/II - Dasatinib an... | NCT01498445 |
| Active | HIV-1 Infection | >BMS-986001 >BMS-986001 >BMS-986001 >Placebo matching with BMS-986001 >Efavirenz >Lamivudine >Tenofovir | Phase_II | Safety, Efficacy and Dose... | NCT01489046 |
| Active | Leukemia, Myelomonocytic, Chronic Leukemia-Lymphoma | Korean Post-marketing Sur... | NCT01464047 | ||
| Active | Multiple Myeloma | >Elotuzumab >Bortezomib >Dexamethasone >Dexamethasone >Dexamethasone >Dexamethasone | Phase_II | Study of Bortezomib and D... | NCT01478048 |
| Active | Arthritis, Psoriatic | >Placebo matching BMS-945429 >BMS-945429 >BMS-945429 >BMS-945429 | Phase_II | Psoriatic Arthritis Dose ... | NCT01490450 |
| Active | Rheumatoid Arthritis | >BMS-945429 Placebo >BMS-945429 >BMS-945429 >BMS-945429 >BMS-945429 >Methotrexate >Methotrexate >Methotrexate Placebo >Methotrexate >Adalimumab | Phase_II | Phase IIB Rheumatoid Arth... | NCT01373151 |
| Active | Melanoma | >Ipilimumab (BMS-734016) >Vemurafenib | Phase_I Phase_II | Ph I/II Ipilimumab Vemura... | NCT01400451 |
| Active | Depression | >BMS-820836 >BMS-820836 >BMS-820836 >Placebo matching BMS-820836 >BMS-820836 | Phase_I | Japanese Phase 1 Multiple... | NCT01396252 |
| Active | Leukemia | >Dasatinib >BMS-833923 | Phase_II | Phase 2 Dasatinib Combo W... | NCT01357655 |
| Active | Depression | >Placebo matching with BMS-820836 >BMS-820836 >BMS-820836 >BMS-820836 | Phase_II | Long-term Safety and Tole... | NCT01361555 |
| Active | Multiple Myeloma | >Anti-CXCR4 (BMS-936564) >Lenalidomide >Dexamethasone >Anti-CXCR4 (BMS-936564) >Bortezomib >Dexamethasone | Phase_I | Anti-CXCR4 (BMS-936564) A... | NCT01359657 |
| Active | Kidney Transplantation | Evaluating Nulojix (Belat... | NCT01386359 | ||
| Active | Melanoma | >BMS-982470 (recombinant interleukin-21) >BMS-982470 (recombinant interleukin-21) >BMS-982470 (recombinant interleukin-21) >BMS-982470 (recombinant interleukin-21) >Ipilimumab >Ipilimumab | Phase_I | Safety Study of IL-21/Ipi... | NCT01489059 |
| Active | Leukemia, Pediatric | >Dasatinib | Phase_II | Pediatric Philadelphia Po... | NCT01460160 |
| Active | Alzheimer Disease Progressive Supranuclear Palsy | Evaluating Cerebrospinal ... | NCT01348061 | ||
| Active | Small Cell Lung Carcinoma | >Ipilimumab >Placebo matching Ipilimumab >Etoposide >Cisplatin >Carboplatin | Phase_III | Trial in Extensive-Diseas... | NCT01450761 |
| Active | Hepatitis C Virus | >BMS-790052 (HCV NS5A Replication Co-factor Inhibitor) >BMS-650032 (HCV NS3 Protease Inhibitor) >Peginterferon alfa-2a >Ribavirin >Ribavirin | Phase_II | Study With PegInterferon ... | NCT01428063 |
| Active | Multiple Myeloma | >Lenalidomide >Dexamethasone >Dexamethasone >Dexamethasone >Elotuzumab (BMS-901608; HuLuc63) >Lenalidomide >Lenalidomide | Phase_I | Study of Elotuzumab in Co... | NCT01393964 |
| Active | Chronic Myeloid Leukemia | Non-interventional Treatm... | NCT01394666 | ||
| Active | Severe Mental Illness Nicotine Dependence | >Electronic decision support system with CO monitor feedback >Electronic decision support system without CO monitor feedback | Phase_III | Electronic Decision Suppo... | NCT01412866 |
| Active | Migraine | >BMS-927711 (CGRP Antagonist) >BMS-927711 (CGRP Antagonist) | Phase_I | Study to Evaluate the PK ... | NCT01445067 |
| Active | Juvenile Idiopathic Arthritis | An Observational Registry... | NCT01357668 | ||
| Active | Smoldering Multiple Myeloma | >Elotuzumab (BMS-901608; HuLuc63) | Phase_II | Biomarker Study of Elotuz... | NCT01441973 |
| Active | Crohn's Disease | >Placebo >Placebo >BMS-936557 (Anti-IP-10 Antibody) >BMS-936557 (Anti-IP-10 Antibody) >BMS-936557 (Anti-IP-10 Antibody) >BMS-936557 (Anti-IP-10 Antibody) >BMS-936557 (Anti-IP-10 Antibody) | Phase_II | Induction and Maintenance... | NCT01466374 |
| Active | Hepatitis C, Genotype 1 | >BMS-790052 (NS5A Replication Complex Inhibitor) >Ribavirin >Peg-Interferon alfa 2a | Phase_III | Safety and Efficacy Study... | NCT01471574 |
| Active | Alzheimer's Disease | >BMS-241027 >BMS-241027 >BMS-241027 >Placebo matching BMS-241027 | Phase_I | Study to Evaluate the Saf... | NCT01492374 |
| Active | Colorectal Cancer Colorectal Adenocarcinoma | >Brivanib >Irinotecan | Phase_II | Irinotecan Plus Brivanib ... | NCT01367275 |
| Active | Type 2 Diabetes Mellitus High HbA1c Level Inadequate Glycaemic Control | >dapagliflozin >placebo | Phase_III | Evaluation of Safety and ... | NCT01392677 |
| Active | Rheumatoid Arthritis | >Subcutaneous Abatacept | Phase_II Phase_III | Impact of Subcutaneous Ab... | NCT01333878 |
| Active | Rheumatoid Arthritis | >abatacept | Phase_III | Benefits of Injectable Ab... | NCT01351480 |
| Active | Renal Cell Carcinoma Clear-cell Metastatic Renal Cell Carcinoma | >BMS-936558 >Sunitinib >Pazopanib | Phase_I | BMS-936558 (MDX-1106) In ... | NCT01472081 |
| Active | Chronic Lymphocytic Leukemia (CLL) | >Dasatinib | Phase_II | A Study of Dasatinib in C... | NCT01441882 |
| Active | Atazanavir | >atazanavir >Atazanavir(ATZ) and Tenofovir(TDF) >Atazanavir(ATZ) + Ritonavir >atazanavir(ATZ) + tenofovir(TDF) + ritonavir | Phase_I | Two Clinical Trials to Ev... | NCT01368783 |
| Active | Rheumatoid Arthritis | >Placebo >BMS-817399 >BMS-817399 | Phase_II | Proof-of-Concept Study Wi... | NCT01404585 |
| Active | Type 1 Diabetes Mellitus | >Dapagliflozin >Dapagliflozin >Dapagliflozin >Dapagliflozin >Placebo matching Dapagliflozin | Phase_II | BMS - Safety, Pharmacokin... | NCT01498185 |
| Active | Postpartum Depression | >aripiprazole | Phase_II | Aripiprazole and Resistan... | NCT01386086 |
| Active | Diabetes Mellitus, Type 2 | >Placebo matching with Saxagliptin >Metformin IR >Metformin XR >Saxagliptin >Saxagliptin | Phase_III | A Multicenter, Randomized... | NCT01434186 |
| Active | HIV Infection | >Ritonavir boosted Atazanavir + Lamivudine >Ritonavir boosted Atazanavir + 2 NRTIs | Phase_IV | Simplification to Atazana... | NCT01307488 |
| Active | Prostate Cancer | >Ipilimumab >Leuprolide >Goserelin >Degarelix | Phase_II | Ipilimumab + Androgen Dep... | NCT01377389 |
| Active | Chronic Hepatitis C | >BMS-650032 >BMS-650032 >BMS-790052 >BMS-790052 >BMS-791325 >BMS-791325 >BMS-791325 >BMS-791325 | Phase_II | Study to Determine the Ef... | NCT01455090 |
| Active | Myeloid Leukemia, Chronic, Chronic Phase | >Imatinib >Dasatinib | Phase_III | Comparison of Imatinib Ve... | NCT01460693 |
| Active | Hepatitis C Virus (HCV) | >Pegylated Interferon Lambda >Pegylated Interferon Alfa-2a >Ribavirin | Phase_III | Safety and Efficacy Study... | NCT01447394 |
| Active | Depression | >Duloxetine >Escitalopram >BMS-820836 Placebo >BMS-820836 >BMS-820836 >BMS-820836 >BMS-820836 | Phase_II | Efficacy and Safety of Fi... | NCT01369095 |
| Active | Lung Cancer - Non Small Cell | >Ipilimumab >Pemetrexed | Phase_II | Safety and Efficacy Trial... | NCT01471197 |
| Active | HIV | >Atazanavir Sulphate >Ritonavir | Phase_III | Phase IIIB Pediatric ATV ... | NCT01335698 |
| Active | Multiple Myeloma | >Lenalidomide >Dexamethasone >Dexamethasone >Dexamethasone >Dexamethasone >Elotuzumab (BMS-901608; HuLuc63) >Elotuzumab (BMS-901608; HuLuc63) | Phase_III | Phase III Study of Lenali... | NCT01335399 |
Completed Clinical Trials
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Completed | Anorexia Cachexia HIV Infections | >Megestrol acetate | Phase_II | A Study of Different Dose... | NCT00002300 |
| Completed | Acute Coronary Syndrome (ACS) | >Apixaban >Apixaban >Placebo | Phase_II | Safety Study of Apixaban ... | NCT00313300 |
| Withdrawn | Colorectal Carcinoma | >Cetuximab and Radiation Therapy >Surgery and Radiation Therapy | Phase_II | Comparative Study of Cetu... | NCT00725400 |
| Terminated | Breast Cancer | >Alvespimycin | Phase_II | Clinical Trial of Intrave... | NCT00780000 |
| Completed | Bipolar Disorder | >aripiprazole | Phase_III | Study of Aripiprazole in ... | NCT00036101 |
| Completed | HIV Infections | >Atazanavir >Lopinavir/Ritonavir | Phase_III | Atazanavir Versus Lopinav... | NCT00028301 |
| Completed | Ovarian Cancer Peritoneal Neoplasms Fallopian Tube Neoplasms | >Cetuximab: >Paclitaxel >Carboplatin | Phase_II | Phase II Study in Patient... | NCT00063401 |
| Completed | Leukemia, Myeloid, Chronic-Phase Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | >Dasatinib | Phase_I | BMS-354825 in Patients Wi... | NCT00103701 |
| Completed | Rheumatoid Arthritis | >Abatacept | Phase_I | An Exploratory Study of C... | NCT00162201 |
| Completed | Breast Cancer Metastases | >Ixabepilone + Capecitabine >Capecitabine | Phase_III | Novel Epothilone Plus Cap... | NCT00080301 |
| Withdrawn | Kawasaki Disease | >pravastatin | Phase_II | Cardiovascular Risk Marke... | NCT00305201 |
| Completed | Head and Neck Cancer | >Paclitaxel | Phase_II | Early Phase II Study of W... | NCT01024101 |
| Completed | Chronic Hepatitis B | >Entecavir | Phase_II | A Phase II Dose Response ... | NCT01022801 |
| Completed | HIV Infections | >Atazanavir >Stavudine >Didanosine | Phase_II | Safety and Effectiveness ... | NCT00007202 |
| Completed | Melanoma | >Treatment of metastatic melanoma | Phase_II | Comparison Study of MDX-0... | NCT00050102 |
| Terminated | Schizophrenia Schizoaffective Disorder | >aripiprazole | Cognitive Improvement Wit... | NCT00211302 | |
| Completed | Colorectal Carcinoma | >Cetuximab | Phase_II | A Phase II Study of Cetux... | NCT00362102 |
| Completed | Type 2 Diabetes | >Saxagliptin | Phase_I | Assess Pharmacokinetics, ... | NCT00770302 |
| Completed | Atherosclerosis | >BMS-779788 >BMS-779788 >BMS-779788 >Placebo | Phase_I | Multiple-Dose Study to Ev... | NCT00836602 |
| Completed | HIV Infections | >fosamprenavir >ritonavir >saquinavir >atazanavir | Phase_II | Dual Boosted Protease Inh... | NCT00122603 |
| Completed | Tumors Neoplasm Metastasis | >Brivanib >Brivanib >Brivanib >Brivanib >Brivanib >Brivanab | Phase_I | MAD in Cancer Patients: S... | NCT00207103 |
| Completed | Non-Small Cell Lung Cancer | >Pemetrexed >Cetuximab | Phase_I Phase_II | Pemetrexed Plus Cetuximab... | NCT00216203 |
| Completed | Metabolic Syndrome X | >clopidogrel | Phase_IV | PROCLAIM: Study Examining... | NCT00296803 |
| Completed | Myeloid Leukemia, Chronic | >Dasatinib >dasatinib | Phase_I Phase_II | A Study of Dasatinib in C... | NCT00482703 |
| Completed | Transplantation | >belatacept | Phase_I | Subcutaneous Pharmacokine... | NCT00569803 |
| Terminated | Non-small Cell Lung Cancer | >Cetuximab | Phase_II | Cetuximab as Therapy for ... | NCT00694603 |
| Completed | Hodgkin's Disease | >MDX-060 | Phase_II | A Phase II Study of MDX-0... | NCT00284804 |
| Completed | Cancer Tumor | >BMS-690514 | Phase_I | A Phase I Study of BMS-69... | NCT00329004 |
| Completed | HIV Infections | >Ortho Tri-Cyclen (ethinyl estradiol + norgestimate) >Ortho Tri-Cyclen LO (ethinyl estradiol + norgestimate) + Atazanavir/Ritonavir for 14 days then Ortho Tri-Cyclen for 7 days | Phase_I | Atazanavir and Ritonavir ... | NCT00357604 |
| Completed | HIV Infections | >Atazanavir/Ritonavir >Atazanavir/Ritonavir + Famotidine >Atazanavir/Ritonavir + Famotidine >Atazanavir/Ritonavir >Atazanavir/Ritonavir + Tenofovir Disproxil Fumrarate + Famotidine >Atazanavir/Ritonavir + Tenofovir Disproxil | Phase_IV | Drug Interaction Study of... | NCT00384904 |
| Completed | Non-small Cell Lung Cancer | >Ixabepilone + Carboplatin | Phase_I | Ixabepilone in Combinatio... | NCT00683904 |
| Completed | Breast Cancer | >Paclitaxel | Phase_II | Phase II Study of Weekly ... | NCT01023204 |
| Completed | Diabetes Mellitus, Type 2 | >BMS-512148 >BMS-512148 >BMS-512148 >Placebo | Phase_II | A Phase IIA Study of BMS-... | NCT00162305 |
| Completed | HIV Infections | >Structured Treatment Interruption >Zidovudine (ZDV) >Lamivudine (3TC) >Efavirenz (EFV) >Ritonavir (NRV) >Indinavir (IDV) | Phase_III | Randomised Trial of Struc... | NCT00158405 |
| Completed | Conduct Disorder | >Aripiprazole | Phase_IV | Trial of Aripiprazole in ... | NCT00250705 |
| Completed | Deep-Vein Thrombosis | >Apixaban | Phase_II | Oral Direct Factor Xa-inh... | NCT00252005 |
| Completed | Cardiac Surgery | >Pentaspan | Phase_II Phase_III | Double Blind Randomized T... | NCT00337805 |
| Terminated | Diabetes, NOS | >Dapagliflozin | Phase_I | Renal Mechanism of Action... | NCT00726505 |
| Completed | Neoplasms | >Dasatinib | Phase_I | Phase I (PH I) Mad Refrac... | NCT00099606 |
| Terminated | Type 2 Diabetes Mellitus | >MK0478 (muraglitazar) >placebo | Phase_III | An Investigational Drug C... | NCT00130806 |
| Completed | Prostate Cancer | >Docetaxel >Carboplatin | Phase_II | A Study of Docetaxel Plus... | NCT00134706 |
| Completed | Psoriasis | >BMS-582949 >Placebo | Phase_I Phase_II | A Study of BMS-582949 in ... | NCT00399906 |
| Completed | Cardiovascular Disease | >Clopidogrel >Aspirin | Phase_I | Ex Vivo Human Thrombosis ... | NCT00935506 |
| Completed | Sarcoma, Kaposi HIV Infections | >Etoposide | Phase_II | Phase II Evaluation of Lo... | NCT00000807 |
| Completed | HIV Infections | >Stavudine >Didanosine | A Comparison of Two Dose ... | NCT00002207 | |
| Completed | HIV Infections | >Stavudine >Zidovudine | A Comparison of Zidovudin... | NCT00002307 | |
| Completed | Head and Neck Cancer | >Cetuximab >Pemetrexed >radiation therapy | Phase_I | Trial of Cetuximab and Pe... | NCT00291707 |
| Withdrawn | Cancer | >Vinflunine >Rifampin | Phase_I | A Study of the Interactio... | NCT00534807 |
| Completed | HIV Infections | >Stavudine | A Study of Stavudine in H... | NCT00002308 | |
| Completed | Chronic Hepatitis B | >Entecavir | Phase_III | A Phase III Study of Ente... | NCT00036608 |
| Completed | Transitional Cell Carcinoma Bladder Neoplasms Kidney Neoplasms Ureter Neoplasms Bladder Cancer Neoplasm, Bladder | >vinflunine | Phase_II | Vinflunine in Patients Wi... | NCT00101608 |
| Completed | Type 2 Diabetes Mellitus | >Muraglitazar >Pioglitazone | Phase_III | Study of Muraglitazar Ver... | NCT00106808 |
| Terminated | HIV-Associated Lipodystrophy HIV Infections | >poly-L-lactic acid >poly-L-lactic acid | Phase_IV | Facial Lipoatrophy Trial:... | NCT00126308 |
| Completed | Malignant Melanoma | >Ipilimumab+ Placebo >Ipilimumab+ Budesonide | Phase_II | A Study of MDX-010 (BMS-7... | NCT00135408 |
| Completed | Schizophrenia Schizoaffective Disorder Social Anxiety Disorder | >Aripiprazole | Phase_IV | Aripiprazole for the Trea... | NCT00177008 |
| Completed | Non-small Cell Lung Cancer | >KOS-1584 | Phase_II | Study to Evaluate KOS-158... | NCT00651508 |
| Completed | Metastatic Breast Cancer | >Ixabepilone | Phase_II | A Rollover Study of Ixabe... | NCT01027208 |
| Terminated | Lung Cancer | >KOS-862 | Phase_II | Effectiveness of KOS-862 ... | NCT00080509 |
| Completed | Schizophrenia and Schizoaffective Disorder | >Aripiprazole | Phase_III | A Study of Aripiprazole i... | NCT00292409 |
| Terminated | Obesity | >BMS-646256 >Placebo | Phase_II | Multiple-Dose Study to Ev... | NCT00388609 |
| Completed | Hypertension | >IRBESARTAN | Phase_IV | The Efficacy and Safety o... | NCT00562809 |
| Completed | Parkinson's Disease Psychoses | >aripiprazole | Phase_IV | Aripiprazole in Patients ... | NCT00095810 |
| Completed | Mucinous Gastrointestinal Adenocarcinoma | >cetuximab | Phase_II | A Trial of Erbitux for Re... | NCT00162110 |
| Completed | Lung Cancer | >Paclitaxel >Carboplatin | Phase_II | Preoperative or Postopera... | NCT00193310 |
| Completed | Schizophrenia | >Aripiprazole | Phase_IV | Effect on Cognitive Funct... | NCT00329810 |
| Completed | Ulcerative Colitis | >abatacept >placebo >abatacept | Phase_III | A Study of Abatacept in P... | NCT00410410 |
| Terminated | Non Small Cell Lung Cancer | >BMS-663513 | Phase_I | A Study of BMS-663513 in ... | NCT00461110 |
| Completed | HIV Infections | >Nelfinavir mesylate >Lamivudine >Stavudine >Zidovudine >Didanosine | A Comparison of Two Tripl... | NCT00002411 | |
| Completed | Bipolar Disorder | >aripiprazole | Phase_III | Aripiprazole in Patients ... | NCT00095511 |
| Complete | Hepatitis B Chronic Disease | >Entecavir | Entecavir for Subjects Wi... | NCT00096811 | |
| Terminated | Ovarian Cancer | >Cetuximab | Phase_II | A Study in Patients With ... | NCT00082212 |
| Completed | HIV Infections | >emtricitabine, FTC (drug) >didanosine, ddI (drug) >efavirenz (drug) | Phase_III | Once Daily Antiretroviral... | NCT00196612 |
| Completed | HER2 or EGFR Expressing Advanced Solid Malignancies | >BMS-599626 | Phase_I | MAD Refractory: Solid Tum... | NCT00207012 |
| Completed | Hypertension | >irbesartan and irbesartan-hydrochlorothiazide | Phase_IV | AMISH : Aprovel for Manag... | NCT00264212 |
| Completed | Bipolar Disorder | >Lamotrigine + Aripiprazole >Lamotrigine + Placebo | Phase_IV | A Phase IV Study of the S... | NCT00277212 |
| Completed | HIV Infections | >Efavirenz (EFV), Emtricitabine (FTC), Tenofovir DF (TDF) | Phase_IV | Single Tablet Regimen (ST... | NCT00365612 |
| Completed | Depression | >BMS-820836 >BMS-820836 >BMS-820836 >BMS-820836 >BMS-820836 >BMS-820836 >BMS-820836 >BMS-820836 >BMS-820836 >BMS-820836 | Phase_I | Single Dose Study of BMS-... | NCT00964912 |
| Completed | Pediatric Solid Tumors | >Carboplatin >Irinotecan >Irinotecan | Phase_I Phase_II | A Study to Document Long-... | NCT00990912 |
| Completed | Schizophrenia | >Aripiprazole >Olanzapine or Quetiapine or Risperidone | Phase_III | Schizophrenia Trial of Ar... | NCT00237913 |
| Completed | Urothelial Carcinoma | >Ipilimumab | Phase_I | Study of Neoadjuvant Ipil... | NCT00362713 |
| Completed | Diabetes | >Saxagliptin >Saxagliptin >Glyburide >Placebo >Glyburide >Metformin | Phase_III | A Study of Saxagliptin in... | NCT00313313 |
| Completed | Sarcoma, Kaposi HIV Infections | >Interferon alfa-2b >Didanosine | Phase_II | The Safety and Effectiven... | NCT00001114 |
| Completed | Alzheimer Disease | >aripiprazole | Phase_III | Study of Aripiprazole in ... | NCT00036114 |
| Completed | Bipolar Disorder | >Aripiprazole >Placebo | Phase_III | Study of Aripiprazole in ... | NCT00080314 |
| Completed | Non-small Cell Lung Cancer | >Carboplatin >Cetuximab | Phase_II | Carboplatin Plus Cetuxima... | NCT00097214 |
| Terminated | Tumors | >Dasatinib + Ketoconazole | Phase_I | Study of Dasatinib in Pat... | NCT00162214 |
| Completed | Colorectal Cancer | >cetuximab >oxaliplatin >leucovorin >5-fluorouracil >5-fluorouracil >cetuximab | Phase_III | Study of Cetuximab, Oxali... | NCT00061815 |
| Completed | HIV Infections AIDS | >efavirenz; didanosine EC; lamivudine | DART I - A Phase IV Study... | NCT00116415 | |
| Completed | Type 2 Diabetes Microalbuminuria Hypertension | >Irbesartan treatment | Phase_III | Irbesartan in Type 2 Diab... | NCT00317915 |
| Completed | Diabetes | >Saxagliptin >Saxagliptin >Metformin >Placebo >pioglitazone | Phase_III | A Phase 3 Study of BMS-47... | NCT00327015 |
| Completed | Chronic Hepatitis C | >BMS-790052 >Placebo | Phase_I Phase_II | A Single Ascending Dose S... | NCT00546715 |
| Completed | Carcinoma, Non-Small-Cell Lung | >Epothilone | Phase_II | A Phase II Study of Epoth... | NCT00035516 |
| Completed | HIV Infections AIDS | >efavirenz, stavudine extended release, lamivudine | Phase_IV | DART II - A Phase IV Stud... | NCT00116116 |
| Completed | Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis | >Cetuximab | Phase_I | An Exploratory Pharmacoge... | NCT00207116 |
| Completed | Chronic Myeloid Leukemia Blast Crisis | >Dasatinib | Phase_II | Dasatinib (BMS-354825) in... | NCT00101816 |
| Completed | Bipolar Disorder | >Aripiprazole | Phase_III | An Open-Label Trial of Ar... | NCT00221416 |
| Completed | Bipolar Disorder | >aripiprazole | Phase_I | Drug-Drug Interaction Stu... | NCT00321516 |
| Completed | HIV Infections | >Atazanavir + Ritonavir + Combivir | Phase_I | Pharmacokinetics of Ataza... | NCT00326716 |
| Completed | Myocardial Infarction | >Clopidogrel (Iscover/Plavix) | Phase_III | CIPAMI-Study: Clopidogrel... | NCT00372216 |
| Completed | Cancer | >EVRI (BMS-690514) | Phase_I | Pharmacokinetics and Meta... | NCT00578916 |
| Completed | HIV Infection Hyperlipidemia | >Atazanavir >current antiretroviral regimen | Phase_III | Switch to Atazanavir and ... | NCT00225017 |
| Completed | HIV Infection | >HIV drug resistance tests based upon genotype testing | Phase_IV | Can Resistance Enhance Se... | NCT00262717 |
| Completed | Puerperal Sepsis | >Intrapartum Cefoxitin (2g) vs. placebo | Prophylactic Intrapartum ... | NCT00343317 | |
| Terminated | HIV Infections | >Emivirine >Hydroxyurea >Nevirapine >Stavudine >Didanosine | Phase_II | The Safety and Effectiven... | NCT00002418 |
| Completed | HIV Infections | >Efavirenz >Lamivudine >Stavudine | Phase_III | Effectiveness and Safety ... | NCT00005918 |
| Completed | Non-Small-Cell Lung Carcinoma | >Cetuximab + Gefitinib | Phase_I | A Phase I Study of Cetuxi... | NCT00162318 |
| Completed | Myocardial Ischemia Hypertension | >Irbesartan | Phase_III | ARCHIPELAGO: Irbesartan i... | NCT00296218 |
| Withdrawn | Chronic Myeloid Leukemia Acute Lymphoblastic Leukemia | >Dasatinib | Phase_II Phase_III | Study of Dasatinib in Ima... | NCT00349518 |
| Terminated | Chronic Kidney Disease | >pravastatin >vitamin E | Phase_IV | Anti-Oxidant Therapy In C... | NCT00384618 |
| Completed | Advanced Solid Tumors | >BMS-777607 | Phase_I Phase_II | Multiple Ascending Dose S... | NCT00605618 |
| Completed | Chronic Myelogenous Leukemia Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | >dasatinib | Phase_I Phase_II | Rollover Study of BMS-354... | NCT01030718 |
| Completed | Colorectal Neoplasms | >Cetuximab | Phase_II | A Study of Cetuximab in P... | NCT00055419 |
| Completed | Dementia Alzheimer's Disease | >Aripiprazole >Placebo | Phase_III | Intramuscular Aripiprazol... | NCT00095719 |
| Completed | Coronary Artery Disease Ischemia | >Abciximab | Phase_IV | EArly Discharge After Tra... | NCT00169819 |
| Completed | Deep Vein Thrombosis Pulmonary Embolism | >Enoxaparin + Placebo >Apixaban + Placebo | Phase_III | Study of an Investigation... | NCT00423319 |
| Completed | Edema | >Prototype device (unnamed) worn-no pressure given (placebo) from inflatable cuffs >Prototype device(unnamed)-A battery operated inflatable pneumatic cuffs >Prototype device(unnamed)-A battery operated inflatable pneumatic cuffs | Phase_II | Compression Device Safety... | NCT00732719 |
| Terminated | HIV Infections | >Emivirine >Hydroxyurea >Delavirdine mesylate >Stavudine >Didanosine | Phase_II | The Safety and Effectiven... | NCT00002420 |
| Completed | Colorectal Neoplasms Metastases Neoplasm | >cetuximab | Phase_II | Erbitux (Cetuximab) Given... | NCT00083720 |
| Completed | Obesity | >BMS-830216 >Placebo >BMS-830216 >Placebo | Phase_I | Safety Study to Evaluate ... | NCT00878020 |
| Terminated | Breast Cancer | >BMS-275291 | Phase_II | A Randomized, Placebo-Con... | NCT00036621 |
| Completed | Major Depressive Disorder | >Pexacerfont >Escitalopram >Placebo | Phase_I Phase_II | Study of BMS-562086 in th... | NCT00135421 |
| Completed | Hypertension | RIAT Registry: Reason for... | NCT00258921 | ||
| Completed | HIV Infections Protease Inhibitor | >Atazanavir Sulphate >Atazanavir Sulphate >Atazanavir Sulphate | Phase_I | Atazanavir Twice Daily | NCT00357721 |
| Completed | HIV Infections | >Ritonavir >gp160 Vaccine (Immuno-AG) >Stavudine >Didanosine | Phase_I | A Phase I/II Double-Blind... | NCT00000822 |
| Completed | Metabolic Syndrome Hypertension | >Irbesartan >Hydrochlorothiazide | Phase_IV | Irbesartan in the Treatme... | NCT00110422 |
| Completed | Breast Cancer | >paclitaxel | Phase_III | Fluorouracil, Epirubicin,... | NCT00129922 |
| Completed | Schizophrenia Schizoaffective Disorder Bipolar Disorder Metabolic Syndrome X | >Aripiprazole | Phase_IV | The Effects of Aripiprazo... | NCT00224822 |
| Completed | Breast Cancer | >Ixabepilone + Capecitabine | Phase_I | A Phase I Study of Ixabep... | NCT00568022 |
| Completed | HIV Infections | >Zidovudine >Didanosine | Phase_II | A Multicenter Phase II Do... | NCT00000823 |
| Completed | Major Depressive Disorder | >Antidepressant + Placebo >Antidepressant + Aripiprazole >Antidepressant + Placebo | Phase_III | A Study of Adjunctive Ari... | NCT00095823 |
| Terminated | Tumors | >BMS-663513 | Phase_I Phase_II | Study of BMS-663513 in Pa... | NCT00309023 |
| Completed | Neuropathic Pain | >BMS-741672 >Placebo | Phase_II | BMS-741672 for Diabetic N... | NCT00683423 |
| Completed | Venous Insufficiency | >Placebo - No device worn >Prototype device(unnamed)-A battery operated inflatable pneumatic cuffs >Prototype device(unnamed)-A battery operated inflatable pneumatic cuffs >Prototype device(unnamed)-A battery operated inflatabl | Phase_II | Compression Device Safety... | NCT00732823 |
| Completed | HIV Infections | >Zidovudine >Didanosine | The Effects of Anti-HIV D... | NCT00001024 | |
| Completed | HIV Infections | >Nelfinavir mesylate >Stavudine >Didanosine | Phase_III | Comparison of Two Anti-HI... | NCT00002224 |
| Completed | Body Weight Change Schizophrenia Schizoaffective Disorder Psychotic Disorder | >Aripiprazole | Phase_III | Effects of Aripiprazole i... | NCT00095524 |
| Terminated | Advanced Solid Tumors | >Ixabepilone (oral formulation) | Phase_I | Phase 1 Trial of Oral Ixa... | NCT00632424 |
| Completed | Thrombosis | >Clopidogrel >Clopidogrel | Phase_III | CASTLE (Clopidogrel And S... | NCT00716924 |
| Completed | HIV Infections | >Zidovudine >Didanosine | Phase_II | Evaluation of Patients Wh... | NCT00001025 |
| Completed | HIV Infections | >Zidovudine >Zalcitabine >Didanosine | Phase_II | A Randomized, Double-Blin... | NCT00000625 |
| Terminated | Tumors | >BMS-275183 | Phase_I | A Phase I Study of BMS-27... | NCT00207025 |
| Completed | Psoriasis Vulgaris | >Abatacept | Phase_I | A Study to Assess the Pha... | NCT00277225 |
| Terminated | Advanced Solid Malignancies | >BMS-663513 | Phase_I | A Study of BMS-663513 Adm... | NCT00351325 |
| Completed | Generalized Anxiety Disorder | >pexacerfont >escitalopram >placebo | Phase_II Phase_III | Study of Pexacerfont (BMS... | NCT00481325 |
| Completed | Chronic Hepatitis C | >BMS-791325 >Placebo | Phase_I Phase_II | A Single Ascending Dose S... | NCT00664625 |
| Complete | Renal Transplantation | >Belatacept | A Belatacept Compassionat... | NCT00719225 | |
| Completed | HIV Infections | >Rosiglitazone maleate >Atazanavir Sulphate >Atazanavir Sulphate + Rosiglitazone maleate >Atazanavir Sulphate + Ritonavir >Atazanavir Sulphate + Ritonavir + Rosiglitazone maleate | Phase_I | Drug Interaction Study Wi... | NCT00362726 |
| Completed | Alzheimer Disease | >Interacting drugs - Cooperstown Cocktail (midazolam, warfarin, (+ vitamin K), caffeine, omeprazole and dextromethorphan) >BMS-708163 >BMS-708163 + Cooperstown Cocktail | Phase_I | Drug Interaction Study Wi... | NCT00726726 |
| Completed | Schizophrenia | >aripiprazole | Phase_II Phase_III | Study of Alternate Formul... | NCT00036127 |
| Completed | Schizophrenia | >Aripiprazole >Aripiprazole >Aripiprazole >Placebo | Phase_IV | Study of Three Doses of A... | NCT00080327 |
| Completed | Non-small Cell Lung Cancer | >Cetuximab >Carboplatin >Paclitaxel | Phase_II | Trial of Carboplatin/Pacl... | NCT00097227 |
| Complete | HIV Infection | >Efavirenz | An Expanded Access Study ... | NCT00162227 | |
| Completed | Melanoma | >ipilimumab (MDX-010, BMS-734016) | Phase_II | A Single Arm Study of Ipi... | NCT00289627 |
| Terminated | Gastrointestinal Neoplasms | >BMS-582664 | Phase_I | Study of BMS-582664 in Co... | NCT00300027 |
| Completed | HIV Infections | >Didanosine | A Treatment IND (Investig... | NCT00002028 | |
| Completed | HIV Infections | >Atazanavir + Ritonavir >Atazanavir + Ritonavir | Phase_I | Bioequivalence Study of A... | NCT00393328 |
| Complete | Advanced Malignancies | >Tanespimycin | Phase_I Phase_II | Clinical Trial of Continu... | NCT00779428 |
| Completed | HIV Infections | >Zidovudine >Zalcitabine >Didanosine | Phase_II | A Comparison of Three Tre... | NCT00001029 |
| Completed | HIV Infections | >Lamivudine/Zidovudine >Nelfinavir mesylate >Stavudine >Didanosine | Phase_III | Evaluation of an Anti-HIV... | NCT00002429 |
| Terminated | Multiple Sclerosis | >Placebo >BMS 188667 (Abatacept) >BMS 188667 (Abatacept) | Phase_II | A Study to Evaluate the P... | NCT00035529 |
| Completed | Hyperlipidemia HIV Infections | >Atazanavir | Phase_III | Atazanavir or Boosted Ata... | NCT00160329 |
| Completed | Advanced Solid Tumors Neoplasms | >Ixabepilone >Capecitabine | Phase_I | Effect of Capecitabine on... | NCT00207129 |
| Terminated | Prostate Cancer | >KOS-862 | Phase_II | Study of KOS-862 (Epothil... | NCT00104130 |
| Completed | Diabetes Mellitus, Type 2 | >muraglitazar | Phase_III | Study Comparing Muraglita... | NCT00095030 |
| Completed | Cancer | >vinflunine + ixabepilone | Phase_I | A Study of the Alternativ... | NCT00362830 |
| Completed | Deep Vein Thrombosis Pulmonary Embolism | >Enoxaparin + Placebo >Apixaban + Placebo | Phase_III | Study of an Investigation... | NCT00452530 |
| Completed | Non-small Cell Lung Cancer | >Oral Taxane | Phase_I Phase_II | Oral Taxane in Combinatio... | NCT00103831 |
| Completed | Neuroendocrine Carcinoma | >Paclitaxel >Carboplatin >Etoposide | Phase_II | Paclitaxel, Carboplatin, ... | NCT00193531 |
| Terminated | Cancer | >Oral Taxane | Phase_I | A Phase I Study of a Sing... | NCT00326131 |
| Withdrawn | Lung Neoplasms Carcinoma, Non-Small-Cell Lung | >Cetuximab >Paclitaxel >Carboplatin | Phase_II | A Study to Determine Whet... | NCT00768131 |
| Completed | Metastatic Melanoma | Long-term Data Collection... | NCT00928031 | ||
| Completed | Leukemia | >Dasatinib | Phase_I | Chronic Myelogenous Leuke... | NCT00978731 |
| Completed | HIV Infections | >Atazanavir + ritonavir + tenofovir + nucleoside >Atazanavir + saquinavir + tenofovir + nucleoside >Lopinavir/ritonavir + tenofovir + nucleoside | Phase_III | Atazanavir (BMS-232632) i... | NCT00035932 |
| Completed | Rheumatoid Arthritis | >Abatacept >Placebo >Abatacept | Phase_III | A Phase III Study of BMS-... | NCT00048932 |
| Completed | Bipolar I Disorder | >Aripiprazole >Placebo | Phase_III | A Study of Aripiprazole i... | NCT00094432 |
| Completed | NSCLC Stage IIIB Concomitant Radiochemotherapy | >Paclitaxel, vinorelbine, cisplatin | Phase_II | Chemoradiotherapy of NSCL... | NCT00198432 |
| Completed | Head and Neck Cancer | >Paclitaxel >cisplatin | Phase_II Phase_III | A Phase II Trial Neoadjuv... | NCT00337532 |
| Completed | Type 2 Diabetes | >Saxagliptin >Placebo | Phase_III | Evaluate Efficacy and Saf... | NCT00698932 |
| Completed | Chronic Hepatitis B | >Entecavir | Phase_III | A Phase III Study of Ente... | NCT00035633 |
| Completed | Overweight Hyperlipidemia Cardiovascular Diseases | >Aripiprazole | Phase_IV | The Effect of Switching t... | NCT00222833 |
| Completed | Cancer Breast Cancer | >Ixabepilone + Capecitabine >Capecitabine | Phase_III | Epothilone (Ixabepilone) ... | NCT00082433 |
| Completed | Diabetes Mellitus, Type 2 | >Saxagliptin >Saxagliptin >Placebo >pioglitazone >rosiglitazone >metformin | Phase_III | A Study Assessing Saxagli... | NCT00295633 |
| Completed | HIV Infections | >Efavirenz >Adefovir dipivoxil >Lamivudine >Didanosine | Phase_II | Safety and Effectiveness ... | NCT00002234 |
| Completed | HIV Infections | >Atazanavir/Ritonavir/Lopinavir/ritonavir | Phase_I | Effect of HIV Protease In... | NCT00135434 |
| Completed | Non-small Cell Lung Cancer | >Cetuximab >Vinorelbine (Navelbine) | Phase_II | Cetuximab and Vinorelbine... | NCT00165334 |
| Completed | Rheumatoid Arthritis | >Tetanus + pnemococcal vaccines alone >Abatacept + vaccines >Abatacept + vaccines >Abatacept + Vaccines | Phase_I | Vaccination Study of Abat... | NCT00279734 |
| Complete | Rheumatoid Arthritis | >MDX-1342 | Phase_I | Study of the Safety of MD... | NCT00639834 |
| Completed | HIV Infections | >Zidovudine >Didanosine | Double-Blind Comparison o... | NCT00002035 | |
| Completed | Esophageal Cancer | >Radiation Therapy >Surgery >Tissue Sample | Phase_II | Cetuximab and Radiation T... | NCT00319735 |
| Completed | Rheumatoid Arthritis, NOS | >BMS-582949 >Placebo | Phase_II | PoC in Rheumatoid Arthrit... | NCT00605735 |
| Completed | Depressive Disorder, Major | >Abilify (aripiprazole) | Phase_IV | Abilify as an Adjunctive ... | NCT00220636 |
| Completed | Hypertension | >Irbesartan | Phase_IV | APROVE : Irbesartan in Hy... | NCT00283036 |
| Completed | Solid Malignancies | >Ixabepilone | Phase_I | Clinical Study of Ixabepi... | NCT00162136 |
| Completed | Cachexia HIV Infections HIV Wasting Syndrome | >Dronabinol >Megestrol acetate | Phase_I | A Phase I/II Study to Eva... | NCT00000737 |
| Completed | HIV Infections | >Zidovudine >Didanosine | Phase_III | A Randomized Comparative ... | NCT00000637 |
| Completed | Cancer Metastases | >panHer | Phase_I | BMS-599626 in Patients Wi... | NCT00095537 |
| Completed | Transitional Cell Carcinoma of the Urothelial Tract Bladder Cancer Bladder Neoplasms | >vinflunine and best supportive care | Phase_III | Phase III Trial of Vinflu... | NCT00315237 |
| Completed | Hypertension | >Irbesartan (Aprovel) | Phase_IV | I SELECT - Irbesartan In ... | NCT00362037 |
| Completed | Carcinoma, Non-Small-Cell Lung Colorectal Cancer Malignant Melanoma Renal Cancer Prostate Cancer | >MDX-1106 | Phase_I | A Study of MDX-1106 in Pa... | NCT00441337 |
| Completed | Hepatitis B | >Entecavir | Phase_II Phase_III | Study of Adding Entecavir... | NCT00051038 |
| Completed | Congestive Heart Failure | >Irbesartan >Placebo | Phase_III | Irbesartan in Heart Failu... | NCT00095238 |
| Completed | Bipolar Disorder | >Aripiprazole | Phase_IV | Aripiprazole in Late Life... | NCT00194038 |
| Completed | Hypertension Dyslipidemia | >Irbesartan >Ciprofibrate | Phase_IV | Irbesartan, Ciprofibrate ... | NCT00350038 |
| Completed | Irritable Bowel Syndrome | >Placebo >BMS-562086 | Phase_II | A Study of BMS-562086 in ... | NCT00399438 |
| Completed | Rheumatoid Arthritis | >Abatacept >Methotrexate >Placebo >Abatacept >Methotrexate | Phase_III | A Phase III Study of Abat... | NCT00409838 |
| Completed | Schizophrenia | >Aripiprazole | Phase_III | A Study of Aripiprazole i... | NCT00237939 |
| Completed | HIV Infections | >Atazanavir+Ritonavir+Tenofovir >Atazanavir+Ritonavir+Tenofovir+Famotidine >Atazanavir+Ritonavir+Tenofovir+Famotidine >Atazanavir+Ritonavir+Tenofovir+Famotidine >Atazanavir+Ritonavir+Tenofovir+Famotidine | Phase_I | Drug Interaction Study Wi... | NCT00365339 |
| Completed | Type 2 Diabetes | >Saxagliptin >Placebo | Phase_III | Treatment Effect of Saxag... | NCT00614939 |
| Completed | HIV Infections | >Atazanavir >Nelfinavir mesylate >Stavudine >Didanosine | Phase_II | Study of a New Protease I... | NCT00002240 |
| Completed | Diabetes Mellitus | >Muraglitazar | Phase_III | PPAR - Combination With M... | NCT00162240 |
| Completed | Melanoma | >ipilimumab (MDX-010, BMS-734016) >Ipilimumab >Ipilimumab | Phase_II | Study of Ipilimumab (MDX-... | NCT00289640 |
| Completed | HIV Infections | >Atazanavir >Atazanavir/Ritonavir >Atazanavir/Ritonavir+Omeprazole >Atazanavir/Ritonavir+Omeprazole >Atazanavir >Atazanavir/Ritonavir >Atazanavir/Ritonavir+Omeprazole >Atazanavir/Ritonavir+Omeprazole | Phase_I | Drug Interaction Study Wi... | NCT00357240 |
| Completed | Candidiasis, Esophageal HIV Infections | >Amphotericin B | Evaluation of Amphoterici... | NCT00002041 | |
| Completed | Colorectal Cancer | >cetuximab >Irinotecan >Irinotecan | Phase_III | Study of Irinotecan and C... | NCT00063141 |
| Completed | Esophagus Cancer | >Paclitaxel >Carboplatin >5-Fluorouracil | Phase_II | Chemotherapy With or With... | NCT00193141 |
| Completed | Rectal Cancer | >Oxaliplatin >Capecitabine >Cetuximab >Radiotherapy >Surgery | Phase_I Phase_II | Safety Study of Cetuximab... | NCT00226941 |
| Completed | Autistic Disorder | >Aripiprazole >Placebo | Phase_III | Study of Aripiprazole in ... | NCT00332241 |
| Completed | Diabetes | >Dapagliflozin >Metformin >Dapagliflozin + Metformin | Phase_I | Drug Interaction With Met... | NCT00546741 |
| Completed | Advanced Cancer IV, NOS | >cetuximab | Phase_II | Study to Evaluate the Eff... | NCT00698841 |
| Completed | Thrombosis | >Apixaban IR >Apixaban MR1 >Apixaban MR2 >Apixaban MR3 | Phase_I | Bioavailability Study Com... | NCT00914641 |
| Completed | Diabetes Mellitus, Non-Insulin-Dependent | >Glucovance (metformin HCl/glyburide) >metformin HCl >glyburide | Phase_III | A Research Study to Deter... | NCT00035542 |
| Terminated | Carcinoma, Non-Small-Cell Lung | >Bexarotene (targretin) | Phase_I Phase_II | A Study of Paclitaxel and... | NCT00153842 |
| Completed | HIV Infections | >Atazanavir + 2 NRTIs >Atazanavir + Ritonavir + 2 NRTIs | Phase_IV | Induction-Maintenance Wit... | NCT00207142 |
| Completed | HIV Infections | >Atazanvir/ritonavir + efavirenz >Atazanvir/ritonavir + efavirenz | Phase_III | A Pilot Study of Atazanav... | NCT00135343 |
| Completed | Chronic Myeloid Leukemia Philadelphia-Positive Myeloid Leukemia | >Dasatinib >Imatinib | Phase_II | Dasatinib (BMS-354835) Ve... | NCT00103844 |
| Completed | Tumors | >dasatinib >dasatinib >dasatinib >dasatinib | Phase_I | Study of Dasatinib(BMS-35... | NCT00339144 |
| Completed | Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer | >Carboplatin >GM-CSF >Interferon Gamma | Phase_II | Chemoimmunotherapy Study ... | NCT00501644 |
| Complete | Chronic Lymphocytic Leukemia | >MDX-1342 | Phase_I | Study of MDX-1342 in Pati... | NCT00593944 |
| Terminated | Bipolar Disorder Metabolic Syndrome | >Aripiprazole | Study of Aripiprazole to ... | NCT00665444 | |
| Completed | Solid Tumors Breast Cancer | >Tanespimycin | Phase_I Phase_II | Clinical Trial of the Com... | NCT00773344 |
| Completed | HIV Infections | >Nevirapine >Zidovudine >Didanosine | Phase_II | Comparison of Three Anti-... | NCT00001045 |
| Completed | Anorexia Cachexia HIV Infections | >Megestrol acetate | Phase_IV | The Safety and Effectiven... | NCT00002345 |
| Complete | HIV Infections | >Atazanavir (BMS-232632) | Atazanavir for HIV Infect... | NCT00046345 | |
| Completed | Major Depressive Disorder | >Antidepressant + Aripiprazole | Phase_III | A Long-Term Study of Arip... | NCT00095745 |
| Completed | Pain | >Paracetamol >Placebo | Phase_IV | Study to Evaluate The Ana... | NCT00344045 |
| Completed | Breast Cancer Metastasis | >Dasatinib | Phase_II | Study of Dasatinib (BMS-3... | NCT00371345 |
| Completed | Head and Neck Neoplasms | >Cetuximab >Docetaxel >Cisplatin >5-Fluorouracil | Phase_I | C-TPF in Patients With Ne... | NCT00402545 |
| Completed | Breast Cancer | >Paclitaxel | Phase_II | Rollover Study of Weekly ... | NCT00971945 |
| Completed | AIDS Dementia Complex HIV Infections | >Stavudine | Phase_III | A Study to Evaluate the U... | NCT00002246 |
| Completed | HIV Infection | >LPV/RTV + 2NRTIs >LPV/RTV + 2NRTIs | Effect of the Atazanavir ... | NCT00096746 | |
| Completed | Non-Small-Cell Lung Carcinoma | >Cetuximab + platinum + gemcitabine >Platinum + Gemcitabine | Phase_II | Study of Gemcitabine/Plat... | NCT00112346 |
| Completed | Coronary Arteriosclerosis Heart Failure, Congestive Myocardial Infarction Myocardial Ischemia Myocardial Stunning | Evaluation of Myocardial ... | NCT00213746 | ||
| Completed | Schizophrenia | >aripiprazole >Placebo | Phase_IV | A Study of Adjunctive Tre... | NCT00300846 |
| Completed | Healthy | >Dasatinib + Omeprazole | Phase_I | The Effect of Omeprazole ... | NCT00655746 |
| Completed | Healthy | >BMS-708163 >BMS-708163 >BMS-708163 >Placebo | Phase_I | Safety Study of Multiple-... | NCT00828646 |
| Completed | Rheumatoid Arthritis | >Abatacept + Methotrexate >Infliximab + Methotrexate >Placebo + Methotrexate >Abatacept | Phase_III | Abatacept and Infliximab ... | NCT00095147 |
| Completed | HIV Infections | A Study of Prevalence of ... | NCT00135447 | ||
| Completed | Chronic Myelogenous Leukemia | >Dasatinib | Phase_II | Study of Dasatinib (BMS-3... | NCT00101647 |
| Completed | Psoriasis Vulgaris | >CTLA4Ig / Abatacept | Phase_II | Phase II Randomized, Doub... | NCT00287547 |
| Completed | Chronic Hepatitis C | >BMS-650032 or Placebo | Phase_I Phase_II | A Single Ascending Dose S... | NCT00559247 |
| Completed | HIV Infections Leukoencephalopathy, Progressive Multifocal | >Filgrastim >Cytarabine >Zidovudine >Zalcitabine >Didanosine | Phase_II | Comparison of Anti HIV Dr... | NCT00001048 |
| Completed | Bipolar Disorder | >Aripiprazole | Phase_III | Study of Aripiprazole in ... | NCT00036348 |
| Completed | Heart Diseases | >BMS-394136 >Placebo | Phase_I | A Phase I Study to Assess... | NCT00162448 |
| Completed | Social Anxiety Disorder (SAD) | >Nefazodone | Phase_IV | Nefazodone in the Treatme... | NCT00231348 |
| Terminated | Cancer | >Oral Taxane | Phase_I | A Phase I Study of BMS-27... | NCT00332748 |
| Completed | Rheumatoid Arthritis | >Abatacept >Placebo | Phase_II | A Study of Abatacept in J... | NCT00345748 |
| Completed | Schizophrenia OCD Obsessive Compulsive Disorder | >Aripiprazole | Aripiprazole in the Treat... | NCT00374348 | |
| Completed | HIV Infections | >Stavudine | A Pilot Study to Compare ... | NCT00002349 | |
| Completed | Arthritis, Rheumatoid | >Abatacept >placebo | Phase_II | Study of Abatacept Versus... | NCT00124449 |
| Completed | HIV Infections | >Nevirapine >Nevirapine + Atazanavir/Ritonavir >Nevirapine + Atazanavir/Ritonavir >Atazanavir + Ritonavir | Phase_I | ATV/Ritonavir Nevirapine ... | NCT00162149 |
| Terminated | Prodromal Schizophrenia Prodromal Psychosis | >aripiprazole | Aripiprazole Treatment of... | NCT00169949 | |
| Completed | Lymphoma Digestive System Diseases Ovarian Diseases Pulmonary Disease Prostatic Disease Bladder Disease | Development of an Evaluat... | NCT00210249 | ||
| Completed | Cancer | >Ixabepilone >Ixabepilone >Ixabepilone | Phase_I Phase_II | Ixabepilone Administered ... | NCT00309049 |
| Completed | Metastatic Pancreatic Cancer | >Ixabepilone + Cetuximab | Phase_II | A Phase II, Trial of Ixab... | NCT00383149 |
| Evaluation of Troponin I Levels | >Perflutren Lipid Microsphere | Prospective Analysis and ... | NCT00575549 | ||
| Completed | Hypertension | >Irbesartan/HCTZ >Irbesartan monotherapy >HCTZ monotherapy | Phase_III | Irbesartan/Hydrochlorothi... | NCT00095550 |
| Terminated | Non-small Cell Lung Cancer | >BMS-275183 (oral taxane) | Phase_II | Study of BMS-275183 in Pa... | NCT00359450 |
| Completed | Diabetes Mellitus, Type 2 | >Dapagliflozin | Phase_I | Renal Impairment in Type ... | NCT00554450 |
| Completed | Diabetes Mellitus, Type 2 | >Dapagliflozin >Glimepiride >Dapagliflozin + Glimepiride | Phase_I | Pharmacokinetic Drug Inte... | NCT00562250 |
| Completed | Malignant Melanoma | >MDX-010 | Phase_I | Study of MDX-010 in Subje... | NCT00729950 |
| Completed | Atrial Fibrillation | >Apixaban >Apixaban >Warfarin sodium | Phase_II | A Phase 2 Study To Evalua... | NCT00787150 |
| Completed | Colorectal Cancer | >Brivanib + Cetuximab | Phase_I | BMS-582664 in Combination... | NCT00207051 |
| Completed | Cancer | >BMS-690514 | Phase_I | Phase I Study of BMS-6905... | NCT00516451 |
| Completed | Type 2 Diabetes | >Dapagliflozin >Metformin XR | Phase_III | An Efficacy & Safety Stud... | NCT00643851 |
| Completed | Cytomegalovirus Infections HIV Infections | >Lobucavir | A Study of Lobucavir in P... | NCT00002352 | |
| Completed | Carcinoma, Non-Small-Cell Lung | >Paclitaxel and carboplatin | Phase_III | Study Comparing Weekly Ta... | NCT00035152 |
| Completed | Acute Coronary Disease Angina Unstable | >clopidogrel (SR25990) >acetylsalicyclic acid (ASA) | Phase_III | Clopidogrel Optimal Loadi... | NCT00335452 |
| Completed | Esophageal Cancer | >Paclitaxel | Phase_II | Phase II Study of Weekly ... | NCT00344552 |
| Completed | Metastatic Breast Cancer | >Ixabepilone >Ixabepilone >Bevacizumab >Bevacizumab >Paclitaxel >Bevacizumab | Phase_II | A Trial of 2 Schedules of... | NCT00370552 |
| Completed | Acute Coronary Syndromes Coronary Artery Disease | >Educational intervention programme | Prospective Registry of O... | NCT00716352 | |
| Withdrawn | Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma. | >MDX-1411 | Phase_I | Study of MDX-1411 in Pati... | NCT00730652 |
| Completed | HIV Infections Chickenpox | >Sorivudine >Acyclovir | Phase_II | Comparison of Brovavir Ve... | NCT00000953 |
| Completed | HIV Infections | >Atazanavir/ Stavidine / Lamivudine >Atazanavir-Ritonavir/ Stavidine / Lamivudine | Phase_IV | Study of Boosted Atazanav... | NCT00084253 |
| Completed | Melanoma Metastases | >MDX-010 (anti-CTLA4) monoclonal antibody >MDX-1379 Melanoma Peptide Vaccine | Phase_III | MDX-010 Antibody, MDX-137... | NCT00094653 |
| Terminated | Psoriasis, Moderate to Severe | >BMS 587101 | Phase_II | Study of BMS-587101 in Pa... | NCT00162253 |
| Completed | Crohn's Disease | >abatacept >placebo >abatacept | Phase_III | A Study of Abatacept in P... | NCT00406653 |
| Completed | HIV Infections | >atazanavir/ritonavir >lopinavir/ritonavir | Metabolic Effects of Swit... | NCT00413153 | |
| Leukemia | >Dasatinib | Korean Early Access Progr... | NCT00454753 | ||
| Completed | Peripheral Arterial Disease | >Clopidogrel (Plavix) | Phase_IV | Effect of Plavix on NO (N... | NCT00648453 |
| Completed | Hepatic Insufficiency | >BMS-790052 | Phase_I | Hepatic Impairment | NCT00859053 |
| Completed | Sarcoma, Kaposi HIV Infections | >Bleomycin sulfate >Vincristine sulfate >Doxorubicin hydrochloride >Zalcitabine >Didanosine | Phase_I | A Study of Chemotherapy P... | NCT00000954 |
| Completed | Non-Small Cell Lung Cancer Stage I and II Peri-Operative Chemotherapy | >gemcitabine, paclitaxel, cisplatin, carbopatine | Phase_III | Stage I/II NSCLC Perioper... | NCT00198354 |
| Terminated | HIV Infections | >Atazanavir | Phase_IV | A Phase IV Study of BMS-2... | NCT00312754 |
| Completed | Chronic Myelogenous Leukemia | >Dasatinib >Dasatinib >Dasatinib >Dasatinib >Dasatinib >Dasatinib | Phase_I Phase_II | Study of BMS-354825 in Su... | NCT00337454 |
| Completed | Breast Cancer Metastasis | >Dasatinib | Phase_II | A Study of Dasatinib (BMS... | NCT00371254 |
| Completed | Parkinson's Disease | >Sinemet® controlled release (Carbidopa/levodopa) | A Multiple-Dose Study of ... | NCT00460954 | |
| Completed | Graft Rejection Kidney Transplantation Renal Transplantation | >LEA29Y, Belatacept | Phase_II | Study Comparing the Safet... | NCT00035555 |
| Completed | Asperger's Disorder Pervasive Developmental Disorder | >aripiprazole | Phase_II | A Study of Aripiprazole i... | NCT00198055 |
| Completed | Metastatic Colorectal Cancer | >Cetuximab | Phase_I | An Exploratory Pharmacoge... | NCT00207155 |
| Completed | Thrombosis Cancer Pulmonary Embolism | >Apixaban >Placebo | Phase_II | A Phase 2 Pilot Study of ... | NCT00320255 |
| Completed | Bladder Cancer Transitional Cell Carcinoma Metastasis | >vinflunine and gemcitabine >placebo and gemcitabine | Phase_II Phase_III | First-Line Treatment of A... | NCT00389155 |
| Completed | HIV Infections | >Zidovudine >Didanosine | Phase_I | A Phase I/II, Open Label ... | NCT00000656 |
| Completed | Breast Cancer | >gemcitabine >doxorubicin >paclitaxel | Phase_II | Gemcitabine, Doxorubicin ... | NCT00128856 |
| Completed | HIV-Associated Lipodystrophy Syndrome | >Atazanavir + ritonavir >boosted PI combination | Phase_IV | Study of Reyataz in HIV-I... | NCT00135356 |
| Completed | Solid Tumor Breast Cancer | >Alvespimycin >Trastuzumab >Paclitaxel | Phase_I Phase_II | Clinical Trial of the Com... | NCT00803556 |
| Completed | Type 2 Diabetes Mellitus | >Dapagliflozin >Glimepiride >Sitagliptin | Phase_I | Pharmacokinetic Drug Inte... | NCT00842556 |
| Completed | AIDS Dementia Complex HIV Infections | >Zidovudine >Didanosine | Phase_II | Comparison of 2',3'-Dideo... | NCT00000657 |
| Completed | Candidiasis, Oral HIV Infections | >Nystatin | Nystatin Pastilles for th... | NCT00002057 | |
| Completed | Myocardial Ischemia | >Intensive medical therapy >Percutaneous Coronary Intervention (PCI) plus intensive medical therapy | Phase_III | Clinical Outcomes Utilizi... | NCT00007657 |
| Completed | Prostate Cancer | >carboplatin >paclitaxel | Phase_II | Paclitaxel and Carboplati... | NCT00049257 |
| Completed | Venous Thrombosis Pulmonary Embolism | >Apixaban >Enoxaparin >Warfarin >Enoxaparin Placebo >Apixaban Placebo | Phase_II Phase_III | BMS-562247 in Subjects Un... | NCT00097357 |
| Completed | Cancer Refractory Solid Tumor | >Cetuximab + Irinotecan >Cetuximab + Irinotecan | Phase_I | Study of Erbitux™ (Cetu... | NCT00110357 |
| Completed | Cancer | >vinflunine + ketaconazole | Phase_I | Effect of Ketoconazole on... | NCT00388557 |
| Completed | HIV Infections | >Atazanavir | Phase_I Phase_II | Pharmacokinetic Study of ... | NCT00411957 |
| Terminated | Metabolic Syndrome Schizophrenia | >Aripiprazole >Continued Antipsychotic (Risperidone or Quetiapine or Olanzapine) | Phase_IV | A Phase 4 Study to Assess... | NCT00508157 |
| Completed | Type 2 Diabetes | >Saxagliptin >Placebo | Phase_III | Safety and Efficacy Study... | NCT00683657 |
| Completed | HIV Infections Chickenpox | >Sorivudine | Phase_III | A Study of BV-araU in the... | NCT00002358 |
| Completed | Major Depressive Disorder | >Antidepressant + Placebo >Antidepressant + Aripiprazole >Antidepressant + Placebo | Phase_III | A Study of Adjunctive Ari... | NCT00095758 |
| Completed | Hypertension | >Irbesartan (Aprovel) | Phase_IV | I PREVENT - Irbesartan In... | NCT00362258 |
| Completed | Type 2 Diabetes | >saxagliptin >sitagliptin | Phase_III | 18-Week Add-on to Metform... | NCT00666458 |
| Withdrawn | Advanced Solid Tumors | >BMS-817378 | Phase_I | Ascending Multiple-Dose S... | NCT00792558 |
| Completed | Arterial Occlusive Diseases | >Clopidogrel | Phase_III | CASPAR : Clopidogrel and ... | NCT00174759 |
| Completed | Autistic Disorder Behavioral Symptoms | >Aripiprazole | Phase_III | Study of Aripiprazole in ... | NCT00365859 |
| Completed | Hepatitis C | >BMS-650032 >BMS-790052 >BMS-650032 >BMS-790052 | Phase_I | Drug-Drug Interaction Stu... | NCT00904059 |
| Completed | Sarcoma, Kaposi HIV Infections | >Etoposide | Phase_I | Phase I Study of Weekly O... | NCT00000660 |
| Completed | HIV Infections | >Didanosine | Phase_I | A Study Comparing Two For... | NCT00002360 |
| Completed | Rheumatoid Arthritis | >Belatacept >Abatacept | Phase_I Phase_II | Phase I/II Multiple-Dose ... | NCT00279760 |
| Completed | Chronic Myeloid Leukemia Philadelphia-Positive Myeloid Leukemia | >dasatinib | Phase_II | Study of BMS-354825 in Pa... | NCT00101660 |
| Completed | Atrial Fibrillation | >Irbesartan >Placebo | Phase_III | Electrophysiological Effe... | NCT00352560 |
| Completed | Actue Coronary Syndromes | >PRAVASTATIN SODIUM | Phase_IV | Pravastatin or Atorvastat... | NCT00382460 |
| Completed | HIV Infections | >Atazanavir >Ritonavir >Tenofovir/emtricitabine | Phase_II | Measure of Pharmacokineti... | NCT00528060 |
| Terminated | Sarcoidosis | >Abatacept | Phase_II | Safety Study of Abatacept... | NCT00739960 |
| Completed | HIV Infections | >Smallpox Vaccine >HIVAC-1e >gp160 Vaccine (MicroGeneSys) | Phase_I | A Comparative Phase I Cli... | NCT00002261 |
| Completed | Schizophrenia Schizoaffective Disorder | >Aripiprazole | Phase_III | Broad Effectiveness: Stud... | NCT00036361 |
| Completed | Acute Coronary Syndromes | >Clopidogrel (SR25990) >Placebo | Phase_III | Clopidogrel as Adjunctive... | NCT00714961 |
| Completed | Breast Cancer Metastases | >Ixabepilone | Phase_II | Novel Epothilone (BMS-247... | NCT00080262 |
| Completed | Attention Deficit Hyperactivity Disorder | >abilify | Phase_IV | Study of Aripiprazole (Ab... | NCT00221962 |
| Completed | Type 2 Diabetes | >Saxagliptin >Placebo >Metformin | Phase_III | Evaluate Efficacy and Saf... | NCT00661362 |
| Completed | Non-small Cell Lung Cancer | >Paclitaxel | Phase_II | Phase II Study of Weekly ... | NCT01024062 |
| Completed | Chronic Hepatitis B | >Entecavir | Phase_II | An Open-Label Rollover St... | NCT01037062 |
| Completed | HIV Infections | >Didanosine | Phase_II | A Study of Dideoxyinosine... | NCT00000963 |
| Completed | HIV Infections | >Stavudine >Zidovudine >Didanosine | Phase_II | The Effectiveness of Thre... | NCT00001063 |
| Completed | Bipolar Disorder | >Enhanced Clinical Intervention | Bipolar Disorder Research... | NCT00211263 | |
| Completed | Hypertension | >Irbesartan >placebo | Phase_III | Randomized, Parallel, Com... | NCT00561964 |
| Completed | Melanoma | >Anti-CD137 (4-1BB) (BMS-663513) | Phase_II | Phase II, 2nd Line Melano... | NCT00612664 |
| Withdrawn | Glioblastoma Multiforme Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligodendroglioma Glioma | >enzyme-inducing anti-epileptic drugs >enzyme-inducing anti-epileptic drugs | Phase_I | Ph. I Dasatinib/Protracte... | NCT00734864 |
| Completed | Head and Neck Cancer | >Paclitaxel | Phase_II | Late Phase II Study of We... | NCT00855764 |
| Completed | Candidiasis, Oral HIV Infections | >Amphotericin B | Phase_II | A Study of Amphotericin B... | NCT00001065 |
| Completed | Unresectable Stage III or IV Malignant Melanoma | >Ipilimumab >Ipilimumab | Phase_I Phase_II | Phase II Study to Determi... | NCT00261365 |
| Completed | HIV Infections | >Viracept versus Sustiva with stavudine and epivir | Phase_IV | Mechanisms of Lipodystrop... | NCT00457665 |
| Completed | Type 2 Diabetes Mellitus | >Bumetanide >Dapagliflozin | Phase_I | Study to Evaluate the Pot... | NCT00930865 |
| Completed | Chronic Hepatitis B | >Entecavir | Phase_II | A Study in Japan of the S... | NCT01020565 |
| Completed | HIV Infections | >Lamivudine >Zidovudine >Didanosine | Phase_II | A Comparison of Zidovudin... | NCT00001066 |
| Completed | Bipolar Disorder | >Placebo >Aripiprazole >Haloperidol | Phase_III | Study of Aripiprazole in ... | NCT00097266 |
| Completed | Rheumatoid Arthritis | >Abatacept | Phase_II | CTLA4IG With Methotrexate... | NCT00162266 |
| Terminated | Leukemia | >Dasatinib >Imatinib | Phase_III | A Study of Dasatinib vs. ... | NCT00362466 |
| Terminated | HIV Infections | >HIV Integrase Inhibitor (BMS-707035) | Phase_II | A Multiple Ascending Dose... | NCT00397566 |
| Melanoma | >Ipilimumab | Compassionate Use Trial f... | NCT00495066 | ||
| Completed | Prostate Cancer | >Vinflunine | Phase_II | Vinflunine in Hormone Ref... | NCT00545766 |
| Completed | Solid Tumors | >Ixabepilone | Phase_I | Study of Ixabepilone (BMS... | NCT01018966 |
| Completed | Chronic Hepatitis B | >Entecavir | Phase_II | Study in Japan of the Saf... | NCT01037166 |
| Completed | Anorexia Cachexia HIV Infections | >Megestrol acetate | Phase_III | A Study Comparing Megestr... | NCT00002067 |
| Terminated | HIV Infections | >Atazanavir >Nelfinavir mesylate | Phase_III | A Comparison of Atazanavi... | NCT00028067 |
| Completed | Hypertension | >Irbesartan | Phase_IV | Irbesartan in Hypertensio... | NCT00265967 |
| Withdrawn | Lymphoma, Large-Cell | >MDX-060 | Phase_II | MDX-060 in Patients With ... | NCT00298467 |
| Completed | HIV Infections | >Atazanavir + Ritonavir | Phase_III | Study to Evaluate the Saf... | NCT00337467 |
| Withdrawn | Obesity and Type 2 Diabetes | >ibipinabant | Phase_II Phase_III | BMS-646256 in Obese and O... | NCT00541567 |
| Completed | Split-Thickness Donor Sites. | >Aquacel Ag Gelled >Aquacel Ag Adherent | Phase_III | Comparative Evaluation of... | NCT00731367 |
| Completed | Type 2 Diabetes Mellitus | >Saxagliptin | Phase_I | Pharmacokinetics and Phar... | NCT00935467 |
| Completed | Head and Neck Cancer | >Paclitaxel | Phase_II | Rollover Study of Weekly ... | NCT00971867 |
| Completed | Rheumatoid Arthritis | >MDX-1100 >Placebo | Phase_II | Study of MDX-1100 (Anti-C... | NCT01017367 |
| Completed | HIV Infections | >Indinavir sulfate >Lamivudine >Stavudine >Zidovudine >Didanosine | A Comparison of Two Anti-... | NCT00002168 | |
| Completed | Diabetes Mellitus, Non-Insulin-Dependent | >Glucovance (metformin HCl/glyburide) >or Metformin HCl alone >or Glyburide alone. | Phase_IV | A Research Study to Asses... | NCT00035568 |
| Completed | Rheumatoid Arthritis | >BMS-188667 >Methotrexate >Placebo >BMS-188667 >Methotrexate | Phase_III | A Phase III Study of BMS-... | NCT00048568 |
| Completed | AIDS | >Compliance | Phase_IV | To Assess Compliance With... | NCT00207168 |
| Completed | Liver Diseases | >Dasatinib >Dasatinib >Dasatinib | A Study of Dasatinib to S... | NCT00382668 | |
| Completed | Hypertension | >Irbesartan vs atenolol | Phase_II Phase_III | Irbesartan and Atenolol i... | NCT00389168 |
| Completed | HIV Infections | >Didanosine | Phase_I | A Phase I Safety and Phar... | NCT00000669 |
| Completed | HIV Infections | >Indinavir sulfate >Lamivudine >Stavudine >Zidovudine | A Comparison of Epivir Pl... | NCT00002369 | |
| Completed | Schizophrenia | >Aripiprazole >Aripiprazole | Phase_III | Aripiprazole Oral Accepta... | NCT00101569 |
| Completed | HIV Infections | >stavudine extended-release, lamivudine, efavirenz | Phase_III | Switching HIV-1 Infected ... | NCT00135369 |
| Completed | Schizophrenia Schizoaffective Disorder Bipolar Disorder Major Depressive Disorder Anxiety Disorders Substance Abuse | >Aripiprazole | Phase_IV | Abilify Therapy for Reduc... | NCT00208169 |
| Completed | Tumors | >Brivanib >Brivanib | Phase_I | A Phase I Study to Determ... | NCT00435669 |
| Completed | Hepatitis C | >MDX1106-02 >Placebo | Phase_I | A Study of MDX-1106 to Tr... | NCT00703469 |
| Completed | HIV Infections | >Nevirapine >Zidovudine >Didanosine | Phase_II | A Comparative Study of a ... | NCT00000770 |
| Completed | Type 2 Diabetes | >Muraglitazar | Phase_III | A Study to Evaluate Combi... | NCT00240370 |
| Completed | Type 2 Diabetes | >Dapagliflozin >Placebo | Phase_II Phase_III | A Pilot Study of BMS-5121... | NCT00357370 |
| Completed | HIV Infections Dyslipidemia | >ATAZANAVIR | Phase_IV | Effect of Atazanavir on E... | NCT00447070 |
| Completed | Type 2 Diabetes Mellitus | >Saxagliptin >Metformin IR (glucophage) >Saxagliptin + Metformin (FDC) | Phase_I | Bioequivalence Study of S... | NCT00899470 |
| Completed | HIV Infections | >Zidovudine >Didanosine | Phase_II | A Phase II Efficacy Study... | NCT00000671 |
| Completed | HIV Infections | >Indinavir sulfate >Lamivudine >Stavudine >Zidovudine | Phase_III | The Safety and Effectiven... | NCT00002371 |
| Myocardial Infarct Hyperglycemia | >Insulin (tight blood glucose control) | Phase_IV | Impact of Tight Glycaemic... | NCT00237471 | |
| Completed | Healthy | >3 days at 10 mg, 4 days at 1 mg and 7 days at 20 mg. | Phase_I | Aripiprazole and Effexor ... | NCT00362271 |
| Completed | Behavioral Symptoms Autistic Disorder | >Aripiprazole >Placebo | Phase_III | Study of Aripiprazole in ... | NCT00337571 |
| Completed | Multiple Myeloma | >tanespimycin and bortezomib | Phase_II Phase_III | A Study of Tanespimycin (... | NCT00514371 |
| Completed | Type 2 Diabetes Mellitus | >Dapagliflozin | Phase_I | Study of the Absolute Ora... | NCT00908271 |
| Completed | HIV Infections | >Ribavirin >Didanosine | Phase_I | A Phase I Open-Label Stud... | NCT00000772 |
| Completed | HIV Infections | >Didanosine | Phase_II | An Efficacy Study of 2',3... | NCT00000672 |
| Completed | Bipolar Disorder | >aripiprazole | Phase_III | Study of Aripiprazole in ... | NCT00257972 |
| Completed | Neoplasms | >Epothilone D (KOS-862) | Phase_I | A Trial to Evaluate Epoth... | NCT00030173 |
| Completed | Neoplasms | >carboplatin + irinotecan >irinotecan | Phase_II | A Phase II Study of Carbo... | NCT00057473 |
| Completed | Hypertension | >Irbesartan (Aprovel) | Phase_IV | I SAVE - Irbesartan in Mi... | NCT00335673 |
| Terminated | Bipolar Disorder | >Aripiprazole >Placebo | Phase_III | A Study of Aripiprazole i... | NCT00338273 |
| Completed | Atrial Fibrillation Vascular Risk | >clopidogrel (SR25990C) >placebo | Phase_III | Atrial Fibrillation Clopi... | NCT00249873 |
| Completed | HIV Infections Leukoencephalopathy, Progressive Multifocal | >Didanosine | A Study of ddI in Patient... | NCT00002274 | |
| Completed | Schizophrenia Psychosis | >Aripiprazole | Phase_II Phase_III | Aripiprazole Treatment of... | NCT00237874 |
| Completed | Metastatic Breast Cancer | >Ixabepilone and Epirubicin | Phase_I | Phase I Combination w/ Ep... | NCT00322374 |
| Completed | Diabetes Mellitus, Type 2 | >Dapagliflozin >placebo | Phase_I | Phase I Multiple-Ascendin... | NCT00538174 |
| Completed | Congenital Heart Defects Blood Platelet Disorders | >Clopidogrel (SR25990) | Phase_II | Platelet Aggregation Inhi... | NCT00115375 |
| Completed | Metabolics Diabetes Nos | >Muraglitazar | Phase_III | PPAR-COMBO With Sulfonylu... | NCT00162175 |
| Completed | Type 2 Diabetes Mellitus | Detection of Ischemia in ... | NCT00769275 | ||
| Completed | Alzheimer Disease | >BMS-708163 >BMS-708163 + Ketoconazole >Ketoconazole >Fluconazole >BMS-708163 + Fluconazole | Phase_I | Drug-Drug Interaction (DD... | NCT00860275 |
| Completed | HIV Infections | >Hydroxyurea >Nelfinavir mesylate >Stavudine >Didanosine | A Pilot Open Label Trial ... | NCT00002176 | |
| Completed | Depression | >Drug Abilify | Phase_II | Aripiprazole as Augmentat... | NCT00174876 |
| Completed | Type 2 Diabetes | >dapagliflozin >dapagliflozin >dapagliflozin >dapagliflozin >dapagliflozin >placebo >metformin | Phase_II | A Trial of BMS-512148 in ... | NCT00263276 |
| Completed | Coronary Artery Disease | >aspirin >clopidogrel | Phase_IV | Clopidogrel and Aspirin T... | NCT00343876 |
| Terminated | Stomach Cancer | >Vinflunine | Phase_II Phase_III | A Study of Vinflunine in ... | NCT00359476 |
| Terminated | Carcinoma, Non-Small-Cell Lung | >Dasatinib | Phase_II | Phase II Study Evaluating... | NCT00564876 |
| Completed | Antivirals/HIV | >Rifabutin >Rifabutin + Atazanavir + Ritonavir | Phase_I | Drug Interaction Study | NCT00646776 |
| Withdrawn | Chronic Lymphocytic Leukemia | >Dasatinib >Combination of Bendamustine + Dasatinib >Dasatinib >Combination of Bendamustine + Dasatinib | Phase_I | Study of Dasatinib and Be... | NCT00872976 |
| Completed | Type 2 Diabetes Mellitus | >Dapagliflozin >Warfarin >Digoxin | Phase_I | Study of the Effect of Da... | NCT00904176 |
| Completed | HIV Infections | >Hydroxyurea >Nelfinavir mesylate >Stavudine >Didanosine | A Pilot Open Label Trial ... | NCT00002177 | |
| Terminated | HIV Infections | >Tenofovir >Atazanavir >Ritonavir | Phase_II | Efficacy and Safety of Te... | NCT00122577 |
| Completed | Neoplasms | >Cetuximab + Erlotinib | Phase_I | Study of Cetuximab in Com... | NCT00207077 |
| Withdrawn | Myeloid Leukemia, Chronic, Chronic-Phase | >Dasatinib in combination with imatinib | Phase_I | Phase I Study of Dasatini... | NCT00324077 |
| Completed | Heart Defects, Congenital | >clopidogrel (SR25990C) >placebo | Phase_III | Efficacy And Safety Of Cl... | NCT00396877 |
| Completed | Metastatic Breast Cancer | >Ixabepilone | Phase_II | Clinical Study of Ixabepi... | NCT01019577 |
| Completed | Alzheimer Disease | >aripiprazole | Phase_III | Study of Aripiprazole in ... | NCT00041678 |
| Completed | Breast Cancer Adenocarcinoma | >MDX-010 | Phase_II | Study of MDX-010 in Stage... | NCT00083278 |
| Completed | Systemic Lupus Erythematosus | >Abatacept >Placebo >Prednisone >Abatacept | Phase_II | Abatacept in the Treatmen... | NCT00119678 |
| Terminated | Atrial Fibrillation Vascular Risk | >clopidogrel (SR25990C) | Phase_III | Atrial Fibrillation Clopi... | NCT00243178 |
| Completed | Psoriasis Vulgaris | >Abatacept | Phase_I | Phase I Study of BMS-1886... | NCT00306878 |
| Completed | Hypercholesterolemia | >Pravastatin | Phase_IV | Pravastatin Efficacy and ... | NCT00529178 |
| Withdrawn | Hepatitis B, Chronic | >Lamivudine >Entecavir >Adefovir | Phase_IV | Entecavir Plus Adefovir i... | NCT00986778 |
| Completed | HIV Infections | >Zidovudine >Didanosine | Phase_II | Comparison of ddI Versus ... | NCT00000979 |
| Terminated | Non-small Cell Lung Cancer | >BMS-275183 | Phase_II | Study of BMS-275183 in Pa... | NCT00099879 |
| Completed | Rheumatoid Arthritis | >Abatacept | Phase_II | The Study of Abatacept in... | NCT00162279 |
| Completed | Bipolar Disorder Mania | >aripiprazole (Abilify) | Phase_IV | Aripiprazole for the Trea... | NCT00181779 |
| Completed | HIV Infections | >Reyataz + Ritonavir + Truvada >Kaletra + Truvada | Phase_III | BMS-Reyataz Study in Trea... | NCT00272779 |
| Completed | Cancer | >CT-322 | Phase_I | CT-322 in Treating Patien... | NCT00374179 |
| Completed | Antiplatelet Aggregation | >Blood Collection | Phase_IV | A Study to Evaluate the D... | NCT00493779 |
| Completed | Type 2 Diabetes Mellitus | >Dapagliflozin >Placebo | Phase_III | Safety and Efficacy of Da... | NCT00736879 |
| Completed | HIV Infections | >Didanosine | A Study of ddI in Childre... | NCT00002280 | |
| Completed | Polycythemia Vera | >Dasatinib | Phase_II | Dasatinib in Polycythemia... | NCT00538980 |
| Complete | Multiple Myeloma | >Tanespimycin >Bortezomib | Phase_III | A Study of Tanespimycin (... | NCT00546780 |
| Completed | HIV Infections | >Nevirapine >Zidovudine >Zalcitabine >Didanosine | Phase_II | A Randomized, Double-Blin... | NCT00000781 |
| Completed | Rheumatoid Arthritis | >Abatacept >Placebo >Abatacept | Phase_III | Phase III Study of BMS-18... | NCT00048581 |
| Completed | Hypertension | >Irbesartan >Irbesartan | Phase_IV | Irbesartan in Chinese Hyp... | NCT00334581 |
| Completed | HIV Infections | >Atazanavir (immediate switch) >Atazanavir (Week 24 switch) | Phase_III | A Phase IIIB Study Evalua... | NCT00067782 |
| Completed | Rheumatoid Arthritis | >Abatacept | Phase_III | Study of Abatacept (BMS-1... | NCT00124982 |
| Completed | Rheumatoid Arthritis | >abatacept and methotrexate >placebo and methotrexate | Phase_III | Remission in Early Rheuma... | NCT00122382 |
| Completed | HIV Infections | >Videx EC >Epivir >Sustiva | Phase_III | Study Switching HIV-1 Inf... | NCT00135382 |
| Completed | Ulcerative Colitis | >MDX-1100 (anti-CXCL10 human monoclonal antibody) | Phase_I | A Dose-Escalation Study o... | NCT00295282 |
| Completed | Prostate Cancer Neoplasm Metastasis | >MDX-010 | Phase_I Phase_II | Study of MDX-010 in Patie... | NCT00323882 |
| Completed | Diabetes | >Saxagliptin >Saxagliptin >Saxagliptin >Saxagliptin >Placebo >metformin | Phase_III | Study of BMS-477118 as Mo... | NCT00316082 |
| Completed | Atherosclerosis | >Blood draw | An Experimental Medicine ... | NCT00847782 | |
| Completed | HIV Endothelial Dysfunction Inflammation Insulin Resistance | >Salsalate | Phase_II | Safety and Efficacy of Sa... | NCT01046682 |
| Completed | Heart Failure | >Warfarin titrated to an INR of 2.5-3.0 >Aspirin >Clopidogrel | Phase_III | Warfarin and Antiplatelet... | NCT00007683 |
| Completed | Diabetes Mellitus II | >Muraglitazar | Phase_II Phase_III | Dose Ranging Study With L... | NCT00240383 |
| Completed | Deep Vein Thrombosis Pulmonary Embolism | >Enoxaparin + Placebo >Apixaban + Placebo | Phase_III | Study of Apixaban for the... | NCT00371683 |
| Completed | Type 2 Diabetes Mellitus | >simvastatin >Dapagliflozin >simvastatin >valsartan | Phase_I | Pharmacokinetic Drug Inte... | NCT00839683 |
| Completed | HIV Infections | >Atazanavir >Ritonavir >Saquinavir | Phase_II | Safety and Effectiveness ... | NCT00004584 |
| Completed | Bipolar I Disorder | >aripiprazole | Phase_III | Study of Aripiprazole in ... | NCT00046384 |
| Terminated | Chronic Hepatitis B | >Entecavir + Tenofovir >Adefovir + continuing Lamivudine | Phase_III | A Phase IIIb Study to Com... | NCT00605384 |
| Completed | Hepatitis B Chronic Disease | >entecavir >adefovir | Phase_III | Comparative Trial of Ente... | NCT00096785 |
| Completed | Colorectal Cancer | >Cetuximab | Phase_II | A Phase II Trial of Modif... | NCT00251485 |
| Completed | HIV Infections | >Ortho Tri-Cyclen LO >Ortho Cyclen >Ortho Cyclen + Efavirenz >Ortho Cyclen | Phase_I | Drug Interaction - Oral C... | NCT00399685 |
| Terminated | HIV Infections | >Stavudine | Phase_I | A Study of d4T in Patient... | NCT00000686 |
| Terminated | Colorectal Cancer | >Capecitabine and Cetuximab | Phase_II | First-Line Capecitabine a... | NCT00251186 |
| Completed | Prostate Cancer | >AR Antagonist (BMS-641988) | Phase_I | A Phase I Dose-Escalation... | NCT00326586 |
| Completed | Ischemia | >Clopidogrel | Phase_II | ALBION \"Assessment of th... | NCT00360386 |
| Completed | Generalized Anxiety Disorder Panic Disorder | >Aripiprazole | Phase_IV | Aripiprazole for the Trea... | NCT00438386 |
| Completed | Schizophrenia | >Aripiprazole >Olanzapine | Phase_III | Comparative Study of Arip... | NCT00712686 |
| Withdrawn | Leukemia, Myeloid, Chronic | >Ipilimumab | Phase_I | Study of Ipilimumab and D... | NCT00732186 |
| Completed | Schizophrenia | >Aripiprazole >Aripiprazole | Phase_IV | A Switch Study of BMS-337... | NCT00232687 |
| Completed | Diabetes, Type 2 | >Muraglitazar | Phase_III | A Trial to Evaluate BMS-2... | NCT00246987 |
| Completed | Leukemia, Myeloid, Chronic Leukemia, Lymphocytic, Acute, L2 | >Dasatinib | Phase_II | A Study of Dasatinib in P... | NCT00298987 |
| Completed | Chronic Heart Failure | >Irbesartan | Phase_IV | Effect of Irbesartan on I... | NCT00347087 |
| Completed | Type 2 Diabetes | >BMS-686117 >Byetta >Placebo | Phase_I | Study to Evaluate the Saf... | NCT00508287 |
| Completed | Hypertension | >Irbesartan >Irbesartan | Phase_IV | Evaluation of Efficacy an... | NCT00564187 |
| Completed | HIV Infections | >Stavudine | Phase_I | A Study of BMY-27857 in P... | NCT00000988 |
| Completed | Non-Small-Cell Lung Cancer | >Cetuximab | Phase_II | Phase II Study in Patient... | NCT00063388 |
| Complete | HIV Infection | >Efavirenz | An Expanded Access Study ... | NCT00162188 | |
| Completed | Dyslipidemia | >Muraglitazar | Phase_II Phase_III | Efficacy and Safety of BM... | NCT00245388 |
| Completed | HIV Infections Protease Inhibitor | >Atazanavir Sulphate + Ritonavir >Atazanavir Sulphate + Ritonavir + Efavirenz | Phase_I | Dose Finding Confirmation... | NCT00357188 |
| Completed | Prostate Cancer | >BMS-641988 (AR#2) | Phase_I | A Phase I Study of BMS-64... | NCT00644488 |
| Completed | HIV Infections | >Stavudine >Zidovudine | Phase_II | A Randomized, Comparative... | NCT00000789 |
| Completed | Chronic Hepatitis B | >Entecavir | Phase_III | A Phase III Study of Ente... | NCT00035789 |
| Completed | Schizophrenia Schizoaffective Disorder | >Quetiapine or Risperidone + Aripiprazole >Quetiapine or Risperidone + placebo | Phase_IV | Augmentation to Atypicals | NCT00325689 |
| Completed | Albuminuria | >Ramipril + Irbesartan >Ramipril + Placebo | Phase_IV | Irbesartan Versus Placebo... | NCT00095290 |
| Completed | Advanced Solid Tumors Neoplasms | >ixabepilone >Rifampin | Phase_I | Effect of Rifampin on the... | NCT00207090 |
| Completed | Leukemia, Myeloid, Chronic | >Dasatinib >Imatinib | Phase_II Phase_III | Study of Dasatinib in Pat... | NCT00320190 |
| Completed | Healthy | >3 days at 10 mg, 4 days at 15 mg and 7 days at 20 mg | Phase_I | Aripiprazole and Lexapro ... | NCT00361790 |
| Completed | Ulcerative Colitis | >sterile saline for injection >MDX-1100 | Phase_II | A Study of MDX-1100 in Su... | NCT00656890 |
| Terminated | Type 2 Diabetes Mellitus | >BMS-767778 or Placebo | Phase_I | Safety Study to Evaluate ... | NCT00707590 |
| Completed | Type 2 Diabetes Mellitus | >Saxagliptin >Metformin IR (glucophage) >Saxagliptin + Metformin IR (FDC) | Phase_I | Bioequivalence Study of S... | NCT00897390 |
| Completed | Diabetes Mellitus, Type 2 | >Muraglitazar | Phase_III | Mechanism of Action and E... | NCT00094991 |
| Completed | Chronic Hepatitis B Virus | >Entecavir >Entecavir | Phase_III | Continue Entecavir Rollov... | NCT00975091 |
| Completed | Rheumatoid Arthritis | >BMS-582949 and Methotrexate | Phase_I | Multiple Ascending Dose S... | NCT00162292 |
| Completed | Candidiasis, Oral HIV Infections | >Nystatin | A Study of Nystatin in th... | NCT00002293 | |
| Completed | HIV Infections | >atazanavir/ritonavir +2 NRTIs (immediate Switch Group) >LPV/r +2 NRTIs (Delayed/optional Switch Group) | Phase_III | Study of HIV Patients Wit... | NCT00120393 |
| Completed | Healthy | >Dapagliflozin >Dapagliflozin >Moxifloxacin >Placebo to match moxifloxacin and dapagliflozin | Phase_I | Effects of Single Oral Do... | NCT00688493 |
| Completed | Hypertension | >Irbesartan/HCTZ >Irbesartan monotherapy | Phase_III | Irbesartan/Hydrochlorothi... | NCT00095394 |
| Completed | Non-Small-Cell Lung Carcinoma | >Paclitaxel (or Docetaxel) + carboplatin w/ cetuximab >Paclitaxel (or Docetaxel) + carboplatin | Phase_III | Study of Taxane/Carboplat... | NCT00112294 |
| Completed | Chronic Myeloid Leukemia Leukemia, Lymphoblastic, Acute, Philadelphia-Positive | >Dasatinib | Phase_II | Dasatinib (BMS-354825) in... | NCT00101595 |
| Completed | HIV Infections | >Atazanavir+ritonavir >Lopinavir+ritonavir | Phase_III | A Phase IIIb Study Compar... | NCT00135395 |
| Completed | Atrial Fibrillation Cardiovascular Disease | >Irbesartan >placebo | Phase_III | Atrial Fibrillation Clopi... | NCT00249795 |
| Completed | Prostate Cancer | >MDX-010 / MDX-010 + Docetaxel | Phase_II | Comparison Study of MDX-0... | NCT00050596 |
| Completed | Major Depressive Disorder | >Aripiprazole+ ADT >Placebo+ ADT | Phase_III | A Study of Aripiprazole i... | NCT00105196 |
| Completed | HIV Infections | >Atazanavir >Lamivudine/Zidovudine >Efavirenz | Phase_III | A Comparison of BMS-23263... | NCT00013897 |
| Completed | HIV Infections Hepatic Impairment | >efavirenz containing antiretroviral regimen | Phase_I | Pharmacokinetics of Efavi... | NCT00162097 |
| Terminated | Prostatic Neoplasms | >cetuximab >docetaxel | Phase_II | Efficacy and Safety Study... | NCT00448097 |
| Completed | HIV Infections | >Raltegravir >Atazanavir >Atazanavir + Raltegravir | Phase_I | DDI HV (ATV - Merck) | NCT00518297 |
| Completed | HIV Infections AIDS | >stavudine, efavirenz, lamivudine | Phase_III | Rollover Study for Zerit ... | NCT00116298 |
| Completed | Hypercholesterolemia | >Irbesartan | Phase_III | Effect of Irbesartan on E... | NCT00152698 |
| Completed | Carcinoma, Non-Small-Cell Lung | >Cetuximab | Phase_II | Phase II Study of Cetuxim... | NCT00251498 |
| Completed | Alzheimer's Disease Healthy | >BMS-708163 >BMS-708163 >BMS-708163 >BMS-708163 >BMS-708163 | Phase_I | Relative Bioavailability ... | NCT00901498 |
| Completed | Alcoholism | >Aripiprazole >Placebo | Phase_IV | Study of Aripiprazole in ... | NCT00082199 |
| Completed | HIV Infections Antiretroviral Naive | >emtricitabine, FTC (drug) >didanosine, ddI (drug) >efavirenz (drug) | Phase_II | Pilot Study on Once Daily... | NCT00196599 |
| Completed | Healthy Subjects | >Abatacept | Phase_I | Comparability DE vs CD-CH... | NCT00277199 |
| Completed | Type 2 Diabetes Mellitus | >Saxagliptin >Saxagliptin >Saxagliptin >Saxagliptin >Saxagliptin >Saxagliptin >Placebo | Phase_II | Study of Multiple Doses o... | NCT00950599 |
| Completed | Rheumatoid Arthritis | Predictors of Adherence t... | NCT01136707 | ||
| Completed | Rheumatoid Arthritis | Dose Escalation With Remi... | NCT01141413 | ||
| Completed | Depressive Disorder, Major | Impact of Atypical Antips... | NCT01145313 | ||
| Completed | Healthy | >Clopidogrel >Placebo >Omeprazole | Phase_I | Interaction Study of Clop... | NCT01129414 |
| Completed | Healthy | >PF-04620110 | Phase_I | A Single Dose Study Of PF... | NCT01166217 |
| Completed | Rheumatoid Arthritis | >Abatacept combination product (ACP) | Phase_III | Methotrexate - Inadequate... | NCT01173120 |
| Completed | Healthy | >CLOPIDOGREL >placebo | Phase_I | Pharmacodynamic and Pharm... | NCT01123824 |
| Completed | Healthy | >Clopidogrel >Placebo >Pantoprazole | Phase_I | Interaction Study of Clop... | NCT01129427 |
| Completed | Hepatitis B, Chronic | Systematic Review of Anti... | NCT01155427 | ||
| Completed | Diabetes Mellitus | >saxagliptin >metformin XR >saxagliptin + metformin XR (FDC tablet) | Phase_I | Bioequivalence Study of t... | NCT01192139 |
| Completed | Type 2 Diabetes | >dapagliflozin >dapagliflozin >dapagliflozin >dapagliflozin >dapagliflozin >dapagliflozin | Phase_I | Pharmacodynamics, Pharmac... | NCT01135446 |
| Completed | Healthy | >Dapagliflozin/Metformin | Phase_I | Study to Assess the Effec... | NCT01156246 |
| Completed | Rheumatoid Arthritis | Effect of Patient Cost Sh... | NCT01137851 | ||
| Completed | Diabetes Mellitus | >saxagliptin >Glucophage XR >saxagliptin + metformin XR (FDC tablet) | Phase_I | Bioequivalence Study of t... | NCT01192152 |
| Complete | Type 2 Diabetes Mellitus Hypoglycemia | Hypoglycemia: Physician a... | NCT01176656 | ||
| Completed | Healthy | >Clopidogrel | Phase_I | Pharmacokinetic Study of ... | NCT01129063 |
| Completed | Healthy | >clopidogrel >Matching placebo | Phase_I | Food Effect Study on Phar... | NCT01129271 |
| Completed | Healthy | >clopidogrel >placebo >omeprazole | Phase_I | Interaction Study of Clop... | NCT01129375 |
| Completed | Healthy | >clopidogrel >Placebo >omeprazole | Phase_I | Interaction Study of Clop... | NCT01129388 |
| Completed | Leukemia | >Dasatinib (BMS-354825) >Dasatinib (BMS-354825) >Dasatinib (BMS-354825) | Phase_I | Pharmacokinetic Study Com... | NCT01392703 |
| Withdrawn | Stage III or IV Melanoma | >BMS-936559 (Anti-PD-L1) >BMS-936559 (Anti-PD-L1) >BMS-936559 (Anti-PD-L1) | Phase_I | Phase 1 Biomarker Study o... | NCT01455103 |
| Completed | Alzheimer's Disease | >BMS-708163 (Gamma-Secretase Inhibitor) >BMS-708163 (Gamma-Secretase Inhibitor) >BMS-708163 (Gamma-Secretase Inhibitor) >BMS-708163 (Gamma-Secretase Inhibitor) >BMS-708163 (Gamma-Secretase Inhibitor) >BMS-708163 (Gamma-Secret | Phase_I | Study to Evaluate the Saf... | NCT01454115 |
| Completed | Hepatitis B Virus HBV | >entecavir | Phase_II | Safety and Antiviral Acti... | NCT01438424 |
| Completed | Diabetes | >Intramuscular olanzapine, aripiprazole >Intramuscular aripiprazole, olanzapine | Phase_IV | Acute Impact of Intramusc... | NCT01411930 |
| Completed | Dementia, Alzheimer Type | >Aripiprazole (BMS-337039) >Placebo >Aripiprazole (BMS-337039) | Phase_III | Aripiprazole in the Treat... | NCT01438060 |
| Completed | HIV | >Atazanavir >Atazanavir >Atazanavir | Phase_IV | Taste Assessment Study of... | NCT01404572 |
| Completed | Hepatitis B | A Phase IIIb: Long-Term O... | NCT01337479 | ||
| Complete | Recurrent Endometrial Cancer | >Lapatinib and ixempra | Phase_I | A Phase I Study of Lapati... | NCT01454479 |
| Completed | End Stage Renal Disease | >Apixaban >Apixaban | Phase_I | Pharmacokinetics and Phar... | NCT01340586 |
| Completed | Type 2 Diabetes Mellitus | >Saxagliptin/Metformin FDC >Onglyza >Glifage® XR >Saxagliptin/Metformin FDC >Glifage® XR | Phase_I | Bioequivalence (BE) Study... | NCT01365091 |
| Completed | Metastatic Breast Cancer | >paclitaxel plus trastuzumab | Phase_II | Weekly Paclitaxel and Tra... | NCT01423695 |